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Shape-memory polymers (SMPs) are an emerging class of smart materials that 
have the ability to change their shapes in a predefined way when exposed to an external 
stimulus. In the past few years, SMPs have drawn considerable interest because of their 
wide application, expecially in biomedical fields. SMPs have been proved to be suitable 
substitutes to shape-memory alloys due to their flexibility, biocompatibility, 
biodegradability, easy process and wide scope of modifications. Among all SMPs, the 
segmented polyurethanes are more attractive due to their remarkable shape-memory 
property from the phase separation between the hard and the switching segements, which 
also leads to the property related to blood compatibility. Thus, the studing of shape-
memory segmented polyurethane for various biomedical applications becomes more and 
more meaningful and important. In this sense, the aim of this PhD project is to develop 
multifunctional SMPs, combining thermoplastic and elastic properties, shape-memory 
properties, biocompatibility, and biodegradability, for specific biomedical applications.  
More specifically, this project focuses on the preparation of biocompatible and 
biodegradable segmented polyurethane as SMPs with the switching temperature at body 
temperature for the potential implants, such as fast self-expandable stents and drug-
eluting stents. 
Firstly, three-arm poly(caprolactone)-triols (tPCL) were developed as the 
biodegradable switching segment for the preparation of star polymer with shape-memory 
effect around body temperature. Enzymatic ring-opening polymerization of ε-




and good yield. PCL-triols with the melting temperature (Tm) of 45-47 oC were obtained 
by controlling the molecular weight (Mn) between 2720 and 4200 g/mol. The three-arm 
structure of PCL-triols was established by 1H and 13C NMR analyses. Star SMPs were 
prepared in high yield by polymerization of PCL-triols with 4,4'-Methylenediphenyl 
Diisocyanate (MDI) and subsequently with 1,6-hexanediol (HD) in the presence of 
dibulytin dilaurate. The three-arm structures of PCL-triol-co-polyurthene (tPCL-PU) and 
its synthetic intermediate were confirmed by NMR analysis. The switching temperature 
(Ts) of tPCL-PUs could be adjusted by using PCL-triols with different Tm. Ts of 36-39 oC 
was achieved by using PCL-triols with Tm of 45-47 oC and Mn of 2720-4200 g/mol. 
Excellent shape-memory properties of tPCL-PU were demonstrated in cyclic 
thermomechanical tensile tests at 38 oC, with shape recovery in 10 second, shape fixity 
rate (Rf) of 91-92%, shape recovery rate (Rf) of 95-99%. The prepared three-arm 
biodegradable shape-memory polymers with switching temperature at body temperature 
are potentially useful materials for biomedical applications. Expecially, due to their good 
shape-memory property and fast shape-recovery, these SMPs could be used as fast self-
expandable stents.   
For the application as fast self-expandable stent, novel block co-polymers PCL-
triol-co-PHBV PU (PCTBVs) containing hyperbranched PCL as the switching segment 
and microbial polyester poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) as the 
crystallizable hard segment were designed and synthesized in excellent yield. PCTBVs 
showed the desired thermal properties with a Tm of 40 oC from the switching segment, 
determined by hyperbranched PCL, suitable for the thermal switching at body 
temperature and a Tm of 142 oC from the hard segment, stem from PHBV, suitable for the 




of the materials, and their mechanical properties were adjustable by changing the block 
ratio. PCTBV containing 25wt% PHBV (PCTBV-25) showed excellent shape-memory 
property at 40 oC with Rf of 94%, Rr of 98%, and shape recovery within 25s. The 
hyperbrached PCL segment is much better than linear PCL-based one, giving rise to a 
high value of Rf. The novel microbial polyester PHBV hard segment contributed 
significantly to the excellent Rr. Both segments were developed for the first time and 
could be generally useful for the preparation of biodegradable SMPs. PCTBV-25 is a safe 
and biocompatible material according to cytotoxicity tests. The stent made from PCTBV-
25 film showed nearly complete self-expansion at 37 oC in water bath within only 25 s, 
which is much better than the best known biodegradable stents. Therefore, the novel 
biodegradable block co-polymer PCTBV-25 was successfully developed as an excellent 
SMP with thermal switching at body temperature and a biomaterial potentially useful as 
fast self-expandable stent or stent cover.  
With the successful application as fast self-expandable stent, biodegradable SMP 
was designed and developed for another valuable application as drug-eluting stent with 
self-expanability. In this application, the new shape-memory polymer PCTOPDs 
containing hyperbranched three-arm poly(ε-caprolactone) (PCL) as the switching 
segment and poly(2- Oxepane-1,5-dione) (POPD) as the crystallizable hard segment were 
synthesized: P(OPD) with Mn of 1920 g/mol and Tm of 137 oC was prepared by stannous 
octoate-catalyzed ring-opening polymerization (ROP) of OPD with ethylene glycol as 
initiator, which was further reacted with hyperbrached PCL (Mn of 30600 g/mol and a Tm 
of 38.5 oC) via MDI. Polymers were characterized by 1H-NMR, GPC, DSC, tensile test, 
and cyclic thermomechanical tensile test. PCL-triol-co-POPD PU (PCTOPD) showed Tm 




demonstrated as thermoplastic elastomer with good mechanical property [elongation at 
break (εb) of over 980%, maxmimun tensile strength (σm) of 14-20 MPa and Young’s 
modulus (E) of 70-91 MPa) and exhibited excellent shape-memory property at 40 oC, 
with Rf of over 95%, Rr of over 97%, and shape recovery within 30s. PCTOPDs were 
shown as safe materials with good in vitro biocompatibility by cytotoxicity tests. The 
stent made from PCTOPD-27 not only showed almost full self-expansion in phosphate 
buffered saline (PBS) buffer at 37 oC with 45s, but also exhibited collapsed pressure of 
5.8 bar that is higher than the physiological pressure of vessel. Moreover, the drug 
(paclitaxel) release profile showed a linear sustained release manner in the first 10 days 
of 33-42% and continuous release to 30 days of 55-67%.  Therefore, this stent could be a 





CHAPTER 1 INTRODUCTION 
 
 This chapter begins with a brief introduction of the research background followed 
by the thesis objective. Finally, the orgination of thesis will be presented. 
 
 1.1 Shape-memory alloys 
The actual trend in polymer science is to develop intelligent materials1 which are 
predicted to play an important role in the near future for various applications.2 Shape-
memory materials as a class of intelligent materials have the capability to remember their 
original shapes when exposed to external stimulus, e.g. chemicals, pH, or temperature. In 
the past few years, shape-memory materials have attracted significant interests due to 
their widespread applications from vehicle parts to biomedical implants.  
The shape memory effect was first discovered in the sample of gold–cadmium in 
1951,3 which was one of the revolutionary steps in the development of intelligent 
materials. In 1962, Buhler and his co-workers discovered nickel–titanium with shape 
memory effect,4, 5 which was achieved by generating a martensitic phase at a low 
temperature followed by changing to an austenitic phase at a higher temperature.6 Such 
shape-memory effect was observed in many alloys, such as Ni-Ti, Cu-Zn-Al, Cu-Al-Ni 
and iron-based alloys etc.5, 7, 8 Shape-memory alloys (SMAs) have advantages of high 
strength, small size,8-13 biocompatibility6 and superelasticity, leading to significant 
interests towards commercial applications. With over 40 years’ development, SMAs have 
been commercially applied in many fields. Although the usage of SMAs offers desirable 




deformation rate (less than 8%), inherently high stiffness, a limited transition temperature, 
demanding processing and traditional conditions,14 appreciable toxicity15, 16 and non-
biodegradability. This provides motivation for the development of alternative shape-
memory materials. 
  
1.2 Shape-memory polymers 
The most important alternative is shape-memory polymers (SMPs). The first SMP 
was developed by CDF Chimie Company in the mid of 1980s.17  Later on, tremendous 
attraction and efforts have been paid in this area because of its scientific and 
technological significance.14, 18, 19, 20 Compared with SMAs (table 1.114), SMPs show 
vastly different shape-memory characteristics and advantages, including high elastic 
deformation, low cost, low density, easy programming, biocompatibility and potential 
biodegradability. All these characteristics make SMPs more suitable for certain 
biomedical applications, such as sensors, actuators, smart devices, self-healing 
materials21 and media recorders etc.14   
Table 1.1 Comparison of the properties of SMPs with SMAs. 
Physical Properties SMPs SMAs 
Density (g/cm3) 0.9-1.1 6-8 
Deformation (%) 250-800 <8 
Recovery temperature (oC) 25-90 -10-100 
Force required for deformation (MPa) 1-3 50-200 
Recovery stress (MPa) 1-3    150-300 
 
For SMPs, the shape-memory effect is not an intrinsic property. It is a result of 
the combination of overall polymer structure and morphology together with a tailored 




on the molecular structure but also on the mode of deformation as well as the 
programming of stimulus application process. The shape-change process, shown in 
Figure 1.1, includes: i) the original shape A of SMP is formed by traditional process, 
extruding or injection; ii) the polymer is deformed and fixed at a temporary shape B; and 
iii) the shape B returns to the original shape A only when exposed to the external 
stimulus. During this process, the elastic energy is stored and used in the recovery of the 
original shape. On basis of external stimulus, SMPs are mainly divided into light-induced 
and thermally-induced SMPs. The thermally-induced SMPs have a wide application, 
especially in biomedical fields. 
 
Figure 1.1 A simplified scheme for shape-changes of SMP from deformation to recovery 
upon application of external stimulus. 
 
 
1.3 Thermally-induced shape-memory polymers 
 Polymers, exhibiting shape-memory effect, are classified into physically cross-
linked thermoplastics and chemically cross-linked thermosets. Since chemically cross-
linked thermosets are unable to be reshaped after processing due to the high molecular 
interaction, physically cross-linked thermoplastics are more attractive since the easy 
processing technology is becoming more and more important in SMP industry. Among 
the physically cross-linked thermoplastics, segmented polyurethanes (SMPUs) have 




biodegradability and easy production. More importantly, SMPUs display remarkable 
shape-memory properties due to the phase separation between two incompatible 
segments, which brings about properties related to blood compatibility and 
biodegradability.22, 23 For this reason, SMPUs have been used in many biomedical 
applications.  
The microphase separation in SMPUs system facilitates thermal activation of 
shape-memory effect. The thermal activation is associated with the thermal transition of 
switching segment, which can be either the glass transition (Tg) or the melting transition 
(Tm). The glass transition possesses a board transition zone which may retard the shape 
recovery. Thus, the Tm-dependent shape-memory effect is more preferred, which features 
a sharp transition zone for the fast shape recovery.24 To this extent, the most promising 
candidate for Tm-dependent biodegradable switching segment is poly(ε-caprolactone) 
(PCL) whose extensive in vitro and in vivo biocompatibility and efficacy have been 
approved by FDA.25-28 
 
1.4 SMPs with PCL as switching segment and polyurethane as 
hard segment 
PCL is a semi-crystalline and highly thermal stable polyester with a low Tm 60 oC 
and a Tg of -60 oC.29 Linear oligomeric PCL-diol has been used to prepare many shape-
memory SMPUs with polyurethanes as hard segment. However, the linear PCL-based 
SMPs suffer from several challenges. For instance, the swiching temperature (Ts) created 
from PCL segment is hardly to reach body temperature, which is an important parameter 




To meet the challenges, new structure of PCL segment may need to be developed. 
For example, three-arm PCL (PCL-triol) could be selected as switching segment. PCL-
triol showed a 3-fold increase in molecular weight (Mn) while kept the similar Tm 
compared with PCL-diol (Mn=1000 g/mol).30 The increase in Mn of PCL-triol could 
enhance the crystallization ability of the corresponding SMP to achieve shape-memory 
effect at body temperature. PCL-triol has a higher excluded volume which can promote 
the phase separation and the three-arm structure could “pin” the polymer chain to prevent 
it from further slippery, which could be beneficial to shape recovery and fixity. Further 
modification of switching segment could be focused on the preparation of hyperbranched 
PCL that could be also anticipated to increase the crystallization ability. 
 
1.5 SMPs with PCL as switching segment and macrodiol as 
hard segment 
The PCL-PU SMP system generally experiences a dimensional instability after 
processing, thus resulting in insufficient recovery stress, long recovery time and in some 
cases low value of shape-fixity rate. One possible solution to this problem is to use 
polymeric macrodiol as hard segment. For example, microbial polyester poly[(R)-3-
hydroxybutyrate-co-(R)-3-hydroxyvalerate] (PHBV) could be selected as the hard 
segment, due to its good biocompatibility, relatively low degradation rate and high 
Young’s modules for easy adjusting the mechanical properties.31 Except PHBV, poly(2-
Oxepane-1,5-dione) (OPD) could also be a useful hard segment as the same purpose.32 
The use of poly(OPD) could introduce additional hydrogen bonds that could enhance the 




better shape-memory property. In addition, the introduction of more ketones in the 
backbone could increase the negative charge of the surface, possibly lowering down the 
thromgenesis for specific biomedical applications, e.g. stents. 
 
1.6 Biodegradable SMP as fast self-expandable stent 
The use of metallic stents during percutaneous translumial coronary angioplasty 
(PTCA) has been practiced for many years.33 However, the metallic stents may induce 
long-term side effects such as thrombogenesis and intimal hyperplasia.34-36 The short-
term use and long-term compliance of biodegradable polymer with soft tissue provided 
the motivation for the development of new biodegradable materials as fast self-
expandable stents.37 Biodegradable stents had been achieved real self-expansion after the 
incorporation of elastic memory with the fastest expansion time at 2.5 min.38, 39 However, 
the self expansion time, as a very important parameter, is suggested to be ideally less 
than a minute to avoid the migration after deployment.40 The easiest way to speed up the 
self-expansion is to increase elastic memory of materials. For this reason, SMPs should 
be the most promising materials because SMPs exhibit very good elastic memory and can 
complete shape changes within a minute. Thus far, no biodegradable SMP for the reponse 
at body temperatue has been reported for such application. New SMPs containing 
hyperbranched PCL and PHBC may be prepared for such application. 
    
 
1.7 Biodegradable SMP as self-expandable drug-eluting stent 
Drug-eluting stents have been applied in preventing in-stent restenosis in the 




biodegradability in drug-eluting stents, they can be not only expanded to the designed 
artery but also degradaded to non-toxic substrate after completing their function. In the 
only example, the stent needed more than 200 s for nearly self-expansion and the drug 
release was very fast with an apparent burst release in the first 2 days.42 To facilitate self-
expansion and slow down the drug release, new SMPs containing hyperbranched PCL as 
switching segment and poly(2-Oxepane-1,5-dione) (OPD) as hard segment could be 
constructed. PCL is always in a rubbery state at room temperature, which contributes to 
the high permeability for many therapeutic drugs43-45 and it also has a relatively slower 
degradation and remains active for over a year, suitable for drug-eluting purposes.46, 47 
This relatively hydrophobic SMP is expected to be suitable for the delivery of lipophilic 
characteristic of anti-cancer.  
 
1.8 Objective 
The overall objective of this thesis is to design and synthesize of biodegradable SMPs for 
biomedical applications. More specifically, the whole thesis aims to:   
1. develop novel poly(ester–urethanes) as SMPs with switching temperature at body 
temperature based on three-arm PCL as switching segment. Three-arm PCL-triols with 
well-defined structure, controlled molecular weight, and desired thermal properties are 
prepared from the enzymatic syntheses. Novel poly(ester–urethanes) are then synthesized 
from three-arm PCL-troil. The effect of switching segment (PCL-triol) on the thermal, 
mechanical and shape-memory properties of SMPs is examined. The characterization of 
polymers structure, thermal, and mechanical properties, and the investigation of shape-
memory behavior of star polymers will also be conducted.  




SMP containing hyperbranched PCL as switching segment and PHBV as hard segment is 
synthesized and characterized. Their mechanical and shape-memory properties are 
determined. The in vitro cytotoxicity of SMPs will be studied. The first example of using 
SMP as self-expandable stent will also be demonstrated.  
 3. develop novel SMPs system for the first application as drug-eluting stent. SMPs 
containing hyperbranched PCL as switching segment and POPD as hard segment are 
synthesized, structures are characterized and properties are examined. The using SMP as 
drug-eluting stent will be demonstrated. The cytotoxicity of the prepared SMPs will be 
also confirmed by in vivo cell culture in future.  
 
1.9 Thesis organization 
The thesis is organized as following. Chapter 1 presents the brief introduction of 
SMAs, SMPs and objective. Chapter 2 contains literature review on thermally-induced 
SMPs, PCL, PHBV and stents.  Chapter 3 presents materials and characterization 
methods. Chapter 4 is synthesis and characterization of three-Arm poly(ε-caprolactone)-
based poly(ester-urethanes) with shape-memory effect at body temperature. Chapter 5 
deals with biodegradable shape-memory block copolymers for fast self-expandable stents. 
Chapter 6 is about the evaluation of biodegradable SMP as fast self-expandable drug-




CHAPTER 2 LITERATURE REVIEW 
 
Shape-memory polymers (SMPs) present a class of materials that can change 
shapes upon application of external stimulus that can be either direct stimuli such as heat 
48-50 and light,51, 52 or indirect actuation e.g. IR-light,53 electrical fields,54 magnetic fields 
55-57 or immersion in water.58 Most of SMPs reported so far are achieved by using heat as 
a stimulus, and they are named as thermally-induced SMPs. Thermally-induced SMPs 
can be achieved by both indirect and direct actuation. The performance of thermally-
induced SMPs is evaluated by two important parameters, shape-recovery rate (Rr) and 
shape-fixity rate (Rf). 
  
2.1 Parameters for  Character ization of Shape-Memory 
Proper ties 
 The definition of the parameters is as followings: Rr describes the ability to fix 
the deformation and Rf shows the capacity to remember the original shape. 
Generally, the cyclic thermomechanical tensile test is performed to quantify Rr 
and Rf. A description of this method is shown in Figure 2.1.14 In shape-memory cycle, the 
polymer sample is stretched to a constant strain of εm. The sample is rapidly cooled down 
to a temperature lower than Ts under keeping the strain at εm. Then, the force is unloaded 
and a substantial recovery of strain (εu) occurs. The sample is heated above Ts and 
returned to the original shape, resulting in the residue strain (εp). The Rr and Rf for Nth 

































Another method existing for characterization of Rr and Rf is the bending test, 
shown in Figure 2.2.59 In the course of bending test, the sample is initially bent to a 
maximum deformation with an angle θm at a temperature above Ts. The deformed sample 
is cooled down below Ts by keeping the angle θm. Then, the deforming stress is released. 
During the removal, there may be an unconstrained relaxation causing the angle to 
change to θi. Finally, the sample is re-heated to a temperature above Ts and the recovery 




















Figure 2.2 Characterization of shape-memory properties with bending test.59 
 
2.2 Indirect Actuation of Thermally-Induced SMPs 
Thermally-induced SMPs triggered by indirect actuation with IR-light was 
demonstrated in a laser-activated device by Maitland.60 Due to the limitation in the heat 
capacity and thermal conductivity, SMPs showed low shape recovery (Rr). Therefore, 
various materials, such as carbon nanotubes,61, 53 was dispersed or attached to improve 
the shape recovery. Meanwhile, the introduction of carbon-nanotubes led to a certain 
level of electrical conductivity (Cho 2005),54 which may lead to the application of SMPs 
as electroactive actuators. Although light activation employing a particular wavelength of 
light rather than heat is energy saving, it should be noted that light activation has 




enough to let a complete transfer of the light before and after attaining the temporary 
shape. 
Indirect actuation can be also realized by the application of a magnetic field55 or 
immersion into water.58, 62 For example, SMPs were filled with micrometer or nanometer 
iron magnetic particle. Upon the application of a magnetic field, the temperature of this 
SMP increased to activate shape-memory effect.  However, the shape recovery in this 
type of materials was relatively low.  
 
2.3 Direct Actuation of Thermally-Induced SMPs 
Different from the indirect thermal activation, the direct actuation of thermally-
induced SMP is performed by heating. The shape change of a thermally-induced SMP is 
shown in Figure 2.3. The original shape A is designed, and it is deformed into a 
temporary shape B at T1>Ts. The temporary shape B is fixed by cooling down to T2<Ts. 
The sample is then re-heated to T3 (T3>Ts), and original shape A is recovered. The 
‘memory’ of the original shape comes from the stored mechanical energy acquired at the 
reconfiguration and cooling stages of the polymer. Generally, SMP is a system of the 
two-phase heterogeneous structure that consists of at least two segments: switching and 
hard segments. The switching segment, a reversible phase, determines Ts which can be 
either the glass transition (Tg) or the melting transition (Tm) of SMPs. The hard segment, 
a rigid fixed phase, is responsible to memorize the original shape through forming 
physical netpoints or chemical cross-links to inhibit the plastic flow of the chain. On the 
basis of the switching segment, SMPs are classified into Tg-dependent and Tm-dependent 
SMPs. On the basis of hard segment, SMPs are subdivided into physically and 





Figure 2.3 A scheme of thermally-induced SMP changing shapes by heating-cooling 
process. 
 
2.4 Chemically Cross-linked SMPs 
There are three strategies for the preparation of chemically cross-linked SMPs. 
Firstly, they are produced by the cross-linking of linear or branched polymers in the 
presence of ionizing radiation or radical initiator (Scheme 2.1A). Secondly, the polymer 
networks are formed from dimethacrylated oligomers followed by the UV irradiation 
(Scheme 2.1B). Finally, they are synthesized by cross-linking hydroxy-terminated 
multifunction (more than 2) macromonomers with isocyanate (Scheme 2.1C). Similarly, 
chemically cross-linked SMPs could be divided into Tg- and Tm-dependent SMPs based 

















Scheme 2.1 Reaction routes for chemically cross-linked SMPs with different strategies. 
Strategy A: cross-linking of linear or branched polymers in the presence of ionizing 
radiation or radical initiator; Strategy B: UV radiation of methacrylated oligomers; 
Strategy C; cross-linking of hydroxy-terminated multifunction macromonomers with 
isocyanate.  
 
2.4.1 Tg-dependent chemically cross-linked SMPs 
The simplest Tg-dependent chemically cross-linked SMPs are high molecular 
weight polynorborene (PN) and poly(methyl methacrylate) (PMMA). These polymers 
had a high entanglement per chain which functioned as physical cross-linking to form a 
three-dimensional network. Such polymers showed shape-memory effect upon 
application of heating-cooling process. However, high entanglements of polymer 
networks made these polymers difficult to be processed. Besides this, they also had some 
other disadvantages: i) Ts and the modulus plateau were difficult to change; and ii) the 




Except high molecular weight homopolymer, Tg-dependent chemically cross-
linked SMPs could also be poly(ethylene), copolymer of poly(ethylene) and poly(vinyl 
acetate) , and copolyester-urethane network etc. A list of this class of materials is shown 
in table 2.1. 









Poly(ethylene)  60-134 >94 N.R. 63, 64 
 Methyl mathacrylate-co-poly(ethylene glycol) 
dimethacrylate/PEG  56-92 99 - 
65 
poly(rac-lactide)-b-poly(propylene oxide)-b-poly(rac-
lactide) dimethacrylates 10-52 >92 >87 
66 
poly[(L-dilactide)-ran-glycolide] dimethacrylates 62 75 75 67-69 
poly(ethylene glycol) dimethacrylate 56-92 20-98% - 70, 71 
poly(butylene adipate) glycol polyurethane 10-60 99 - 72, 73 
Oligo[(rac-lactide)-co-glycolide] polyurethane                                                                   50-65 >92 >90 73, 74 
Poly(ethylene glycol) polyurethane 50-80 - - 75 
Nature oil copolymer (soybean oil–divinylbenzene, 
soybean oil–styrene–divinylbenzene) 30-110 89-97 30-100 
76-78 
Poly(ketone-co-alcohol) 20-70 90 - 79 
a Ts for switching segmemt for SMPs. b Rr for the shape-recovery rate. c Rf for the shape-
fixity rate. d Ref. for reference. 
 
 
Chemically cross-linked poly(ethylene) (PE) was synthesized by ionizing 
radiation with radical initiator 63, 64, showing shape-memory effect in the range of 60-134 
oC. Although ionizing radiation technology has received much attention in the 
preparation of polymer networks, a new method was developed to replace radical 
initiator due to its potential toxicity. It involved the formation of methacrylate-ended 
macrodiol precursors and cross-linking by photopolymerization without an initiator. 




oxide)-b-poly(rac-lactide) dimethacrylates 66 and poly[(L-dilactide)-ran-glycolide] 
dimethacrylates 67-69 networks. It was found that Ts, mechanical and shape-memory 
properties were highly associated with Mn of macrodiol precursors and crosslinking 
density. In general, a higher Mn of macrodiol precursors resulted in a higher Ts and better 
shape recovery. At low deformation of 30%, Rr of 100% and Rf of over 96% were 
observed at Ts of 10-50 oC. However, an opposite phenomenon was observed in shape-
memory poly(ethylene glycol) dimethacrylate (PEGDMA) networks.70, 71 A lower Ts but 
better recovery were observed at lower Mn. In addition, the content of PEGDMA also 
played an important role: Ts and shape recovery increased with conent of PEGDMA. 
Subsequent research indicated that the increase in crosslink density functionality not only 
lowered the failure strain but also raised rubbery modulus to reach a fast and complete 
recovery.71  
A biodegradable poly(ester-urethane) network was synthesized according to 
Scheme 2.1C. The multi hydroxy-terminated co-oligoester precursor was synthesized and 
then reacted with isocyanate to form networks.73, 74 Ts of this polymer network could 
systematically vary in the range of 14-56 oC by decreasing Mn of precursor or decreasing 
functionality of the netpoints. A higher elongation at breakage (470%) at 70 oC and 
almost complete recovery were observed. 
 
2.4.2 Tm-dependent chemically cross-linked SMPs  
This class of materials is generally more compliant below Ts, with a stiffness that 
is sensitive to the degree of crystallinity, and thus indirectly to the extent of cross-linking. 
This class of materials includes hydrogels, liquid-crystal with phase separated crystalline 




Hydrophilic cross-linked polymers had been widely investigated as water-swollen 
hydrogels, changing shapes under external stimulus.80-83,84 For instance, a gel, made up of 
acrylic acid and n-stearyl acrylated copolymer, displayed strong temperature dependence 
in mechanical properties.85  It behaved as a hard plastic below 25 oC, while it became soft 
and was able to be stretched to 50% at T>50 oC. After temperature cooled down below 
50 oC, the long alkyl chains formed crystals to fix the shape. The gel eventrally recovered 
its original shape by exposing the gel to boiling water86. However, the poor mechanical 
performance and stability limited its applications.  
Liquid crystalline elastomer also showed shape-memory effect which was 
triggered by the thermal transition of the liquid crystalline domains.87, 88 It was heated to 
the isotropic state of the liquid crystalline domains, stretched or twisted, and cooled down 
below the transition temperature to form the semetic-C domains. When the sample was 
re-heated, the permanent shape was recovered. 
Many semi-crystalline rubbers were reported and summarized in Table 2.2. The 
most frequently used method is to form dimethacrylated macrodiol precursor and cross-
linked by UV radiation. Among these, the most widely studied one was PCL 
dimethacrylated (PCLDMA) network.89-91 Similarly, Mn of PCL precursor and content of 
crosslinkes strongly influenced the thermal, mechanical and shape-memory properties of 
the networks. Tm and mechanical properties of the network increased with Mn of PCL 
precursor. The best shape-memory properties were shown with Rr of 92-97% and Rf of 
86-97%.  
 
Table 2.2 Overview of chemically cross-linked SMPs tr iggered by melting transition. 




(oC) (%) (%) 
PCL-co-PEG network 50 99 88 92 
PCL with pendent coumarin group 40-60 95 96 89, 93 
poly(ε-caprolactone) dimethacrylate 10-50 92-97 86-97 89-91 
poly(ε-caprolactone-co-glycolate) dimethacrylate 45 94 97 94 
trans –polycyclooctene 70 - - 95 
Poly(ethylene)-co-poly (vinyl acetate) >60 34-98 95-99 96 
a Ts for switching segmemt for SMPs. b Rr for the shape-recovery rate. c Rf for the shape-
fixity rate. d Ref. for reference. 
  
 Although chemically cross-linked SMPs show high stress, excellent shape-
recovery and tunable work capacity during shape-recovery due to the high molecular 
interaction and chain entanglement, these materials are difficult to reshape after 
processing because of the high chemical cross-links. However, ease of processing has 
been an issue for technological advancement of shape-memory polymers. To this extent, 
physically cross-linked SMPs which display rheological characteristics and are facile to 
be processed with conventional methods are more attractive. 
 
2.5 Physically Cross-linked SMPs 
  Physically Cross-linked SMPs could be homopolymers, block copolymers, and 
segmented polyurethanes (SMPUs). Among these, the most attractive one is SMPUs due 
to the biocompatibility, biodegradability, and ease of process. Generally speaking, 
SMPUs are prepared from polyols, isocyanates and chain extenders. The chain extenders 
are small molecule amine or alcohol. The isocyanates may be aromatic or aliphatic, and 
the most frequently used ones are summarized in Table 2.3. Polyols, including 




polyesters and polyethers. The toughness and flexibility of SMPUs are mainly derived 
from polyols.  
Table 2.3 A descr iption of frequently used isocyanates in the synthesis of SMPs. 
Molecular Structure Chemical Name 
 
Methylene bis(p-cyclohexyl isocyanate) (HMDI) 
 
Methylene bis(p-phenyl isocyanate) (MDI) 
 
1, 4-phenyl diisocyanate (PDI) 
 
Isophorone diisocyanate (IPDI) 
 
Hexamethylene diisocyanate (HDI) 
 
Toluene diisocyanate (TDI) 
  
The synthetic methods for SMPUs are usually divided into two common routes: 
one step- or two step polymerization. In one step polymerization, polyols, isocyanates 
and chain extender are mixed in the same media at the same time (Scheme 2.2A). In the 
two step synthesis (Scheme 2.2B), the reaction includes: in step 1, hydroxyl-terminated 
oligoesters is reacted with an excess of a low molecular weight diisocyanate to form 
isocyanate-terminated prepolymer; in step 2, isocyanate-terminated prepolymer is then 
reacted with chain extender (low molecular weight diols or diamines). The two step 









Scheme 2.2 Schemes for the preparation of SMPUs by (A) one-step polymerization and 
(B) two-step polymerization. 
  
SMPUs show remarkable shape-memory effect due to the microphase separation 
between two incompatible hard and switching segments. The switching segment 
consisting of polyols creates the continuous phase while the hard segment remains 
dispersed and acts as physical cross-linking points. The switching segments can be either 
crystalline or amorphous. Thus, physically cross-linked SMPs are also classified into Tg- 
and Tm-dependent SMPs. 
 
2.5.1 Tg-dependent SMPs 
In this class of SMPs, the glass transition is used to trigger the shape-memory 
effect. Although shape-memory effect has been observed in various homopolymers e.g. 
high molecular weight poly(methyl methacrylate),97, 98 polynorbornene99, 100, the Ts and 
modulus plateau of such polymers were difficult to change, and polymers were difficult 




same as described in Scheme 2.2. So far, many switching segments, such as 
poly(tetrahydrofuran), poly(ethylene adipate), poly(propylene oxide), poly(butylenes 
adipate) and poly(tetrametylene) glycol (PTMG),  have been used.59, 102-112 Among these, 
PTMG is the most frequently used one. It was found that Mn of PTMG and hard segment 
content had effect on shape-memory properties. For example, the influence of hard 
segment content was studied by Lin (1998) 105, 106 and Lee (2001).104 The results showed 
that a higher Tg of SMPs was observed with decreasing Mn of PTMG. At the same hard 
segment content, a lower recovery was found at a higher Mn of PTMG and the 
completely recovery was accomplished at Mn of 250 g/mol. If Mn of PTMG was kept 
unchanged, SMPs showed a fast but incomplete shape-recovery at low content of hard 
segment, while they exhibited a relatively low but complete recovery at high content of 
hard segment. Optimum shape-memory properties were observed at the hard segment 
content of 30-45% with Rr of 90% and Rf of 80-95%. However, it did not show any 
shape-memory effect at extremely low hard segment content (less than 20%) because of 
the failure of generating phase separation. 
The influence of diisocyanate on the shape-memory properties was also 
investigated.112 Compared PDI with MDI, PDI-based SMP showed better properties 
because PDI had a planar shape which resulted in a better interaction among hard 
segment (Figure 2.4). To improve shape-memory properties, aromatic chain extenders 
such as 4,4-bis(4-hydroxyhexoxy)-isopropylene and naphthoxy diethanol were utilized.59 
Subsequent researches about the effect of water vapor permeability on mechanical and 
shape-memory properties showed that water vapor permeability of PU-coated fabrics was 
influenced primarily by concentration of the coating solution.107 With the increase in 
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Figure 2.4 The mechanical property (maximum stress and elongation at break) and shape-
memory properties (Rf) of PDI-based SMPs. 
 
Another commonly used polyols for Tg-dependent SMPs are poly(L-lactide) 
(PLLA) diol. A poly(urethane-urea) SMP was synthesized from PLLA with HDI and 
diamine as chain extender.113 With the presence of urea group in the backbone, higher Rf 
and Rr were obtained due to the higher binding strength as a driving force for phase 
separation. In the end, Rr and Rf reached to 98% and 100%, respectively. Moreover, a 
block copolymer from PLLA-diol and poly(glycolide-co-caprolactone) (PGC-diol) linked 
by HDI exhibited shape-memory effect at 45 oC.114  
The most important thing to achieve the best shape-memory property in 
physically cross-linked Tg-dependent SMPs is the precise control of the structure and 
composition between switching and hard segments. It is required to maintain the high 
molecular interaction to stabilize the hard-segment domain and create phase separation, 
while the switching segment should absorb as high external stress as possible for shape 
recovery. However, the interaction will be destroyed by too much stress, resulting in the 
failure of fixing the permanent shape and showing no shape-memory effect. Moreover, 
the glass transition is often too broad, which may retard the shape recovery. Therefore, 
Tg-dependent SMPs are usually used in the application without the requirement of fast 




2.5.2 Tm-dependent physically cross-linked SMPs 
Aside from the glass temperature as a switching temperature, the melting 
temperature (Tm) can be also used to trigger shape-memory effect. Tm-dependent shape-
recovery speed is faster due to first-order transition with an often sharper transition zone. 
In this class of materials, the switching segment will crystallize to fix temporary shape 
and their Tm values function as Ts. The shape-memory effect is triggered by microphase 
separation during the crystallization of switching segment. A lot of Tm-dependent SMPs 
are reported e.g. polyethylene oxide-co-polyethylene terephthalate, polystyrene-co-
poly(butadiene), poly(2-methyl-2-oxazoline)-co-poly(tetrahydrofuran) and 
poly(caprolactone) (PCL)-based copolymers. Among these, PCL-based biodegradable 
SMPs are widely studied for biomedical applications.  
 
2.5.2.1 PCL-based SMPs with non-crystallizable polyurethane as hard segment 
In SMPUs, SMPs contain high polarity urethanes or uren bonds, served as hard  
Table 2.4 PCL-based segmented polyurethane as SMPs. 
Mn of PCL-diol 
(g/mol) 









1600, 4000, 5000, 
and 7000 MDI+1,4-butanediol 30 44-55 82 82 
115, 116 
4000 HDI+4,4-dihydroxybiphenyl 20-70 38-58 85 90 
117 
500,1000, 2000, 
2500, 3500, 5000, 
8000, and 10000 
TDI+EG 6-61 23.5-48.2 >94% N. R. 
118 
4000 MDI+1,4-BD+BEBP/BEBH 20-43 41-50 85 80 121, 122 









a HS for hard segment content.  b Ts for switching segmemt for SMPs. c Rr for the shape-
recovery rate. d Rf for the shape-fixity rate. e Ref. for reference. 
segment. In fact, a Ts around body temperature is hardly to be achieved with linear PCL 
segment. PCL-based SMPUs are described in table 2.4.50, 115-118 
Many studies showed that the crystallization of PCL segment in PU was hindered 
after the introduction of hard segment, which resulted in Ts of SMPs lower than Tm of 
PCL-diol (Figure 2.5).118  However, the used PCL-diol for SMP synthesis must have a Mn 
higher than 2000 g/mol to show shape-memory effect. No crystallization of PCL segment 
in PU was observed when Mn of PCL is smaller than 2000 g/mol. Thus, it is very difficult 
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Figure 2.5 The plot of Mn of PCL-diol with Tm of PCL-diol and the corresponding PU. 
 To reach the best shape-memory property, it is very important to achieve the 
maximum crystallinity of SMPs. It showed that a higher content and Mn of PCL resulted 
in higher crystallinity of SMPs, beneficial to store much elastic modulus and achieve a 
better Rf (Figure 2.6A).50 Although the shape-recovery increased with Mn of PCL, it 
decreased with increase in switching segment content at low Mn (2000 g/mol) but 
increased with with switching segment content at high Mn (8000 g/mol) (Figure 2.6B). 
Thus, the best shape-memory property was obtained in SMP containing 80 wt% PCL 





























A      B 
Figure 2.6 The relationship between switching segment content and Rf (A) as well as Rr 
(B) for PCL-diol with Mn of 2000 and 8000. 
 
Compared with achieving the maximum crystallinity, the formation of a stable 
hard-segment domain is also very important (Figure 2.7) because the content of hard 
segment determins the phase separation, thus influencing on the shape-memory 
properties. In general, the hard segment content should be high enough to facilitate the 
phase separation. Otherwise, Rr could be very low even with high crystallinity of SMP at 
















Figure 2.7 Relationship between hard-segment content and Rf for PCL-based SMPs. 
 
Moreover, the shape-memory fixity and recovery are also strongly dependent on 




Rr increased and then decreased if the deformation strain applied was changed from 
100% to 600% with PCL of 4000 g/mol (Figure 2.8). Thus, the deformation method also 

















Figure 2.8 Curves for Rf and Rr at different deformation rate. 
 
 
To obtain better shape-memory properties, many methods have been taken to 
enforce microphase separation, stabilize hard segment domains and achieve maximum 
crystallization. Firstly, mesogeic or ionic group is introduced to stabilize the hard 
segment domain. For example, Joeng reported to incorporate mesogenic group in hard 
segment.119, 120 The use of mesogeic segments of BEBP (Scheme 2.3A) or (BHBP) 
(Scheme 2.3B) enhanced solubility of hard segment into PCL switching segment, which 
helped to stabilize the hard domain. As a consequence, Rf was observed to increase more 
than 20%. A recovery stress also increased at the same strain at 65 oC. At the same time, 
the ionomers was also used for the same purpose117, 121. The incorporation of ionic groups 
(DMPA) (Scheme 2.3C) introduced the additional intermolecular interaction to reach 
higher strength and be beneficial to stabilize the hard segment. Accordingly, elastic 





Scheme 2.3 Chemical structures for A) 4,4’-bis(2-hydroxyethoxy)biphenyl (BEBP), B) 
4,4’-bis(2-hydroxyhexoxy)biphenyl (BHBP), and C) dimethylolpropionic acid (DMPA)  
 
 
Secondly, cationomers are also applied to enhance the crystallinity of PCL-
segment.122 The used cationomers were N-methyldiethamine (NMDA) or N,N-bis(2-
hydroxyethyl)isonicotinamide (BIN). The introduction of NMDA cationic groups (6–8 
wt%) into the hard segment enhanced the crystallinity of PCL segment, thus leading to an 
increase in Rr and Rf. However, no significant improvement was observed in BIN-based 
PU. This indicated that the category of cationic groups played an important role . 
Finally, a new deformation method was also studied on the performance of 
SMPs.118 Apart from the conventional deformation method (deformed at a temperature 
higher than Tm), this new deformation method was deformed at a temperature of 10-15 oC 
lower than Tm.118 Simultaneously, the recovery temperature was also below Tm, 
designated as the lowest recovery temperature (LRT). Under this condition, Rr of 94-
100% was observed in all samples. One advantage of this method was that deformed at 
low temperature could prevent the inner stress from releasing and gave a rapid and 
complete recovery. LRT was able to be adjusted by controlling the content Mn of PCL. 
However, the feasibility of this method is limited. 
 
2.5.2.2 PCL-based SMPs with crystallizable macrodiol as hard segment 
Lendlein and Langer reported a shape-memory polymer based on poly(p-




adjusted to 37-40 oC by controlling the Mn of PCL-diol. This SMP showed a recovery 
stress at 1-3 MPa, Rf of about 80% and Rr of over 98%. The potential application as 
sutures was demonstrated 
In contrast to Tg-dependent SMPs, Tm-dependent SMPs features a sharp shape-
recovery. Rr and Rf increase with increase the number cycle in the cyclic 
thermomechanical measurement. Being potentially biodegradable, biocompatible and 
easy processing, Tm-dependent physically cross-linked SMPs are suitable for our target 
application as fast self-expandable stents and drug-eluting stents. 
 
2.6 Chemically and Physically Double Cross-linked SMPs 
Lee and his coworkers developed chemical and physical double networks based 
on PCL and polyhedral oligosilsesquioxane (POSS).124 Physically cross-linked POSS-
PCL was synthesized followed by the UV radiation to form chemically cross-linked 
networks. This system featured a two-way shape-memory effect and good one-way 
shape-memory effect with almost 100% recovery. However, the partially introduced 
chemically cross-links made this polymer difficult to reshape after processing. 
 
2.7 Shape-Memory Composites and Blends 
Compared with SMAs, one major weakness of SMPs is the low strength, stiffness, 
and recovery force. Although, this property of SMPs fits well for the some biomedical 
application, it limits the use for some advanced applications. The simplest way to modify 
their mechanical property would blending48, 125-127 or making composites with other tough 




Zheng and his coworkers reported that PDLLA/HA composites showed shape 
memory effect at 70 oC.130 A quick and good recovery of 95% was found. Liang et al. 
introduced glass and Kevlar fiber to reinforce SMP composites, which led to the 
increase in stiffness but the decrease in recovery.131 After incorporated with glass fiber, 
the elastic modulus increased by approximately a factor of 3.132 Additional  research 
demonstrated the relationship between fiber weight fraction and recoverability for glass 
fiber reinforced SMP composites, prepared by injection molding. The increase in failure 
stress of 140% and decrease in recovery rate of 62% were reported as a result of the 
incorporation of 50 wt% glass fiber.133 Similar observation was reported for SMP 
composites by using carbon fiber reinforcement.134 
Mehl blended PCL with PPDO co-precipitation or co-extrusion method, in which 
PCL acted as switching segment and PPDO served as hard segment.48 An increased 
mechanical property was observed in this polymer blend, which showed a Ts of 34-39 oC 
with Rf of 67-96%. PCL was also blended with styrene-butadiene-styrene tri-block 
copolymer, showing shape-memory effect. 126 
 
2.8 Biodegradable Shape-Memory Systems 
Biomedicine is a very promising field for SMP applications. Synthetic, 
degradable implants have led to dramatic progress in various medical treatments.135, 136 
Stimuli-sensitive implant materials have a high potential for applications in 
minimally invasive surgery. Degradable implants could be inserted into the human body 
in a compressed (temporary) shape through a small incision. After placed into the human 
body, they expand to their relevant application shape after warming up to body 




avoids a follow-on surgery to remove them. 
Designing degradable shape-memory polymers includes: i) select suitable 
netpoints to determine the permanent shape, and ii) choose switching segments to 
determine the switching temperature around body temperature. Furthermore, appropriate 
synthetic strategies have to be developed to provide desired properties. The risk of 
possibly toxic effects of polymers can already be minimized by selecting monomers 
whose homo- or copolymers have been proven to be biocompatible. 
Biodegradable networks with shape-memory effect include PCL dimethacryaltes 
network,89-91 PLLA and PGC dimethacryaltes network, and poly(ester-urethane) 
networks based on PLA.73, 74 As usual, chemically cross-linked SMPs are unable to 
reshape after processing. Thus, more attention would be paid on physically cross-linked 
biodegradable SMPs  
 
2.8.1 Biodegradable thermoplastic elastomers with shape-memory effect 
These polymers are linear multiblock copolymers with a degradable switching 
segment, which is mainly based on well-known biodegradable polymers (crystallizable 
PCL-diol, amorphous PLA and PGC) used in medical fields.  
Lendlein reported a shape-memory polymer based on poly(p-dioxanone) as hard 
segment and PCL as switching segment.123 Taking the advantage of PCL as switching 
segment, Ts of SMPs could be adjusted to 37-40 oC by controlling the Mn of PCL-diol. 
This SMP showed a recovery stress at 1-3 MPa, Rf of about 80% and Rr of over 98%. The 
potential application as sutures was demnonstrated. Nagata et al. synthesized multiblock 
copolymer derived from PCL, 4,4-(adipoyl dioxy)dicinnamic acid and poly(ethylene 




137 PCL/PEG copolymers could exhibit outstanding properties such as hydrophilicity, 
permeability and degradability. It was reported that biodegradability increased with the 
increase in PEG content due to the generation of less tight network as observed from the 
swelling study. PLA, PGC and their copolymer were also used as switching segment to 
prepare biodegradable SMPs. PLA-, or PGC-based SMP showed a glass transition to 
trigger the shape-memory effect. However, Ts is difficult to be adjusted to body 
temperature.113, 138-140 
 
2.8.2 Poly(ε-caprolactone) as biomater ials in biomedical applications  
PCL is a semi-crystalline and highly thermal stable polyester with a Tm of 60 oC 
and a Tg of -60 oC.29 It is biodegraded by hydrolysis of its ester linkages in physiological 
conditions (such as in the human body). PCL is always in a rubbery state at room 
temperature, which contributes to the high permeability of PCL for many therapeutic 
drugs.43-45 To this reason, it has received a great deal of attention for the use in drug 
delivery. Moreover, PCL has a slower degradation rate than PLA and is currently 
regarded as non-toxic and tissue compatible polyester, thus being useful in drug delivery 
devices that remain active for over a year. Extensive in vitro and in vivo biocompatibility 
and efficacy of PCL have been approved by FDA.25-28 In addition, PCL has a relatively 
long biodegradation time, making PCL as suitable material for drug-eluting purposes.46, 47 
 
2.9 Application of SMPs 
Applications of SMPs in various fields have been developed in last 20 years. 




kitchen utensils, from switches to sensor, from intelligent packing to tools. Apart from 
the traditional application, SMPs have also been used as information storage,141, 142 
temperature sensors143, 144 and actuators.145 Recently, researchers are focused on the 
application of SMPs in biomedical fields, such as biodegradable sutures, actuators 
catheters, stents and biomedical devices. SMPs have tremendous applications in biology 
and medicine123, 146 especially for biomedical devices, which might permit new medical 
procedure of minimally invasive surgery. With the development of SMPs, the bulky 
device can be potentially introduced into the body in a small shape by a small 
laparoscopic. After the small shaped device is implanted into the body, a permanent 
shape can be recovered. Due to the biodegradability of SMPs, they can be used as short 
term implants. After finishing their functions, they are degradaded to non-toxic 
substance. 
 
2.9.1 The application of SMPs as smar t suture 
SMPs can be used as a smart suture, which will play an important role in 
endoscopic surgery.123 The challenge of endoscopic surgery is the difficulty to 
manipulate the suture so that the wound lips are pressed together under the right stress. 
When the knot is fixed with a force that is too strong, necrosis of surrounding tissue can 
occur. If the force is too week, scar tissue forms and may lead to the formation of hernias 
due to the poor mechanical properties. A possible solution is to design a smart surgical 
suture, whose temporary shape would be obtained by elongating the fiber with a 
controlled stress. The suture could be applied loosely in its temporary shape. After it was 
applied and the temperature was raised above Ts, it would automatically shrink and 





Figure 2.9 Photographs of shape-memory suture for self wound closure.97 
 
2.9.2 The application of SMPs as stent 
The SMPs as stent application have been predicted to be useful37, 147 because most 
SMPs have free surface energy and negatively charged surface which decreases the side 
of thrombogenesis and initimal hyperplasia.36 Especially, in the area of pediatric stenting, 
SMPs could display their advantages because of their high elongation. With the ability of 
SMPs to memory their permanent shape, the stent can be preprogrammed to activate at 
body temperature, which could result in natural deployment without a need for second 
devices. Another area that polymer may prove useful is the pediatric stenting, in which 
metal stents cannot be sufficiently expanded throughout the growth of patients.148, 149 As 
an example, chemically cross-linked PEGDMA SMP had been examined as stent for 
cardiovascular application, which showed self-expansion at 52 oC in 100s (Figure 2.10). 
150 Since the stent was activated at a temperature higher than body temperature, an 
auxiliary device during deployment was needed for expansion. However, this stent was 
not really self-expandable at body temperature and the non-degradaded nature may be not 
suitable for the coronary application. The forever staying in the human body can cause 
inflammatory and the removal of the auxiliary device may cause vessel injury. Thus, the 
development of biodegradable SMP with self-expansion at body temperature is very 





Figure 2.10 Recovery of a crosslinked SMP stent delivered via catheter into ID glass tube 
containing water at 37 oC.127 
 
2.9.3 The application of SMPs as actuator  
 SMPs have been used as biomimetic actuators,54 which attempt to mimic the 
efficient conversion of chemical energy into mechanical energy in living organisms. For 
example, ionic hydrogels showed a discontinuous volumetric change above a certain 
threshold of an external stimulus such as temperature. Above the transition temperature, 
the phase changed. At the phase-transition point, the volume of swollen phase is several 
hundred times bigger than that of the collapse state. The volumetric transition can exert a 
significant force. An attractive example of utilizing the volumetric change in polymer 
was reported by Nanda Gopal Sahoo and his coworkers.151 Polyurethane-Polypyrrole 
composites showed shape-memory effect with conductivity in Figure 2.11. The transition 
temperature was provided by PCL at near 46 oC. The existence of polypyrrole increased 
the conductivity of the composites. At the proper content polyprrole, composites showed 
electroactive shape recovery after being heated bove the transition temperature. 
 Beside, SMPs are also potentially useful as aneurysm coils,152 nanometer scale 






Figure 2.11 Electroactive shape recovery behavior of PU/PPy=80/20 composite.151 
 
2.10 Enzymatic r ing-opening polymer ization  
2.10.1 The general aspect of r ing-opening polymer ization of lactones 
The lipase-catalyzed ring-opening polymerization (ROP) reaction is a useful 
method for the preparation of polymer with desired structure and molecular weight. The 
first example of lipase-catalyzed ROP was reported by Knani and Uyama in 1993 for the 
polymerization of ε-caprolactone by using crude Porcine pancreatic lipase (PPL) in n-
hexane.156 PCL with molecular weight of 613 to 1924 was obtained in 62.0 to 98.5% 
yield after a long reaction time of 4 to 26 days at 40 oC. Uyama et. al. explored the ROP 
of ε-caprolactone and δ-valerolactone by using different lipases derived from 
Pseudomonas fluorescens (Lipase PF), Candida cylindracea (Lipase B), and Porcine 
pancreas (PPL), respectively.157  The polymerizations were carried out in bulk for 10 
days, PCL with Mn of 1100 to 7700 in 8-92% monomer conversion and PHV with Mn of 
1600 and 1900 in 95% monomer conversion were achieved. The polymerization of ε-
caprolactone at 75 oC gave the highest monomer conversion and polymer molecular 
weight. Thereafter, lipase-catalyzed ring-opening polymerization of various substrates 
with cyclic structure, such as β-propiolactone,158-161 β-butyrolactone,160-163 γ-
butyrolacton,160, 161, 163 δ-valerolactone,157, 161, 164 ε-caprolactone,160, 161, 164-170 8-
octanolide,171, 172 11-undecanolide,161, 173 12-dodecanolide,161, 174 15-pentadecanolide,173, 
175-177 and 16-hexadecanolide178 have been extensively investigated. 
Lipase-catalyzed ring-opening polymerization of cyclic lactones leads to the 
“Green” preparation of polyesters, which are very important materials for biomedical 




Porcine pancreas lipase (PPL), Candida rugosa lipase (Lipase CR), Candida antarctica 
lipase (Lipase CA), Candida cylindracea lipase (Lipase CC), Candida antarctica lipase 
B (CALB), Pseudomonas cepacia Lipase (Lipase PC), Pseudomonas fluorescens Lipase 
(Lipase PF), have been studied. Crude lipases can be directly applied for the ring-opening 
polymerization, but there is always a high amount of lipase will be needed due to the 
deactivate effect of organic solvents. On the other hand, immobilized lipases provided 
better stability than crude lipases, and thus have relatively higher catalytic activity for the 
polymerization. Immobilized lipases can also be easily recycled, and the lower 
production costs became a big advantage over crude lipases. 
 
2.10.2 Mechanism of lipase-catalyzed r ing-opening polymer ization of 
cyclic lactones 
The mechanism of lipase-catalyzed ROP of cyclic lactones has been well studied. 
According to the most accepted theory, the catalytic site from lipase is a serine residue, 
and the ring-opening polymerization was preformed via an acyl-enzyme intermediate. 
The polymerization mechanism was summarized in Scheme 2.4.179, 180 The control step is 
the forming of cyclic lactone-enzyme complex, and thus gave an acyl-enzyme 
intermediate, “enzyme-activated monomer” (EM). The following initiation procedure 
involves the nucleophilic attack of water, which is contained partly in the enzyme, onto 
the acyl carbon of the intermediate to produce a ω–hydroxycarboxylic acid (n=1). Then 
the lipase is released from the acyl-enzyme intermediate for another ring-opening of 
monomer. In the propagation stage, the first linear molecule from the opened cyclic 
monomer perform a nucleophilically attack to the acyl-enzyme intermediate to produce a 











































Scheme 2.4 Mechanism of Lipase-Catalyzed Polymerization of Cyclic Lactones 
 
2.11 Poly[(R)-3-hydroxyalkanoate]s (PHAs) 
2.11.1 General concept of PHAs 
PHAs are produced by a wide variety of microorganisms as carbon storage 
materials (Scheme 2.5).181, 182 Being an important family of natural products, PHAs are 
biorenewable and hence have great advantages over synthetic polymers. Microbial PHAs 
have molecular weights of up to 3,000,000 g/mol, biocompatible and biodegradable, 
which makes them be attractive as biomaterials for applications in both conventional 
medical devices and contemporary tissue engineering. The monomer compositions of 
PHAs are variable and can be manipulated by changing the carbon sources and the 
growth conditions of microorganisms. More than 100 structures of PHAs have been 
reported. Over the past few decades, PHAs and its composites have been widely studied 
and applied to produce biomedical devices including sutures, suture fasteners, meniscus 
repair devices, rivets, tacks, staples, screws, bone plates and bone plating systems, 
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Scheme 2.5 Production of PHAs 
 
The PHA family (Scheme 2.6) includes poly [(R)-3-hydroxybutyrate] (P3HB), 
poly [(R)-4-hydroxybutyrate] (P4HB), poly [(R)-3-hydroxybutyrate-co-hydroxyvalerate] 
(PHBV), poly [(R)-3-hydroxyhexanoate] (PHHx) and poly [(R)-3-hydroxyoctanoate] 


























3-hydroxydodecanoate (3HDD)  
 
Scheme 2.6 Representative Members of PHAs 
 
2.11.2 Poly[(R)-3-hydroxybutyrate] (PHB) 
PHB is the most prominent member of the PHA family, and it was first mentioned 
in scientific literature as early as 1901. The detailed studies were firstly reported by 
Maurice Lemoigne in 1925.185-188 Over the next 30 years, PHB was mainly studied as an 






2.11.2.1 Production of PHB  
PHB can be produced from many aerobic and anaerobic bacterial species under 
nutrient limiting conditions with a sufficient supply of carbon, which is accumulated as 
submicron inclusion bodies.190 Figure 2.12 showed the bacterial cells packed with 
granules of PHB. The amount of PHB in bacterial cells is normally 1-30% of their dry 
weight. However, some Azotobacters and Alcaligenes species can accumulate up to 90% 
of their dry biomass.190-193 The first commercialized PHB was available in 1970s. So far, 
the production of PHB with the bacterial Alcaligenes eutrophus grown on glucose would 
produce up to 70% of its dry biomass as PHB.  
 
Figure 2.12 Transmission electron micrograph of bacterial produced poly(3-
hydroxybutyrate) inclusion bodies. -photo via inhabitat.com 
2.11.2.2 Physical proper ties of PHB 
PHB is a linear saturated polyester with high molecular weight of 105-106, Tm of 
175-180 °C, and glass Tg of 4 °C.181, 194-197 PHB has a high crystallinity of more than 50% 
due to the exceptional stereochemical purity198. PHB has Young’s modulus of 3.5 GPa, 
the tensile strength of 40 MPa for PHB film and the elongation at break of 6%. The 
comparison of physical and mechanical properties of PHB with some common polymers 
were summarized in Table 2.5.181  It can be seen that PHB has an extremely low 




the modification of PHBs. Among these, biosynthesis of co-polyesters containing PHB 
and other PHAs units is another efficient approach to overcome the shortcomings of 
PHB, and to obtain useful PHB-based new materials.  
 
Table 2.5 Physical and mechanical properties of PHB and some common 
polymers.181 
 
Properties P(3HB) Polypropylene Poly(ethylene terephthalate) Nylon-6,6 
Tm (oC) 180 176 267 265 
Tg (oC) 4 -10 69 50 
Crystallinity (%) 60-80 50-70 30-50 40-60 
Density (g/cm3) 1.250 0.905 1.385 1.14 
Water Uptake (wt%) 0.2 1.7 2.9 2.8 
Young’s Modulus (GPa) 3.5 0.0 0.4 4.5 
Tensile Strength (MPa) 40 38 70 83 
Extension at Break (%) 6 400 100 60 
 
2.11.3 Poly(3-Hydroxybutyrate-co-3-Hydroxyvalerate)   
In 1981 Holemes from ICI developed a controlled-fermentation process to 
produce PHBV (Scheme 2.7) by Alcaligenes eutrophus grown in a culture medium 
containing glucose and propionate.199-201 The composition of PHBV has been reported to 
vary from 0-47 mol% P3HV, depending on the composition of the feeding carbon 
substrates.202 The first commercial product of PHBV was produced by ICI and launched 
in Germany in 1990, known as PHBV or Biopol®.203 By using different carbon sources, 
PHBV with a much wider range of compositions can be produced. For example, it was 
founded that PHBV was accumulated in Alcaligenes eutrophus cells in a nitrogen-free 




while the HV content can reach up to 95 mol% by using pentatonic and butyric acid as 







Scheme 2.7 Structure of Poly(3HB-co-3HV) 
 
Compared with PHB, PHBV has much improved physical and mechanical 
properties (Table 2.6). It can be seen that the Young’s modulus, tensile strength and the 
melting temperature have been shown to be regulated by the content of HV units in the 
co-polyester.206 The flexibility and toughness of PHBV is greatly improved by 
incorporating HV units. For instance, the thermal properties and mechanical properties of 
PHB were significantly improved by incorporating 25 mol% HV units in PHBV: the Tm 
changed from 179 oC (original PHB) to 137 oC and Tg from 10 oC to -6 oC; the Young’s 
modulus of PHBV also got a dramatic decrease from 3.5 GPa to 0.7 GPa, while the 
tensile strength remained around 30 MPa.207, 208 The changing compositions also allow 
favorable biocompatibility and degradation times within desirable time frames under 
specific physiological condition.209, 210 
Table 2.6 Polymer properties comparison: PHB and PHB/HV compared with 
conventional plastics.208  
 










PHB 179 10 3.5 40 50 
PHBV(3% HV) 170 8 2.9 38 60 
PHBV(9% HV) 162 6 1.9 37 95 
PHBV(14% HV) 150 4 1.5 35 120 
PHBV(20% HV) 145 -1 1.2 32 200 





2.12 Stents in the treatment of coronary ar ter ies 
Percutaneous transluminal coronary angioplasty (PTCA) has been widely used for 
the treatment of coronary artery diseases. The main limitation of PTCA is restennosis and 
chronic closure. Many methods have been applied to improve PTCA, such as prolonged 
inflation with perfusion balloons, use larger diameter balloons, and coronary artery 
bypass surgery or insertion of stents. Coronary stents are used to overcome the major 
limitation of balloon. The coronary stenting is based on the scaffold affects, allowing the 
intimal and medial flaps to be tacked up to provide a smooth vessel lumen contour.  
 
2.12.1 Metallic stent 
Several metallic stents have been commonly applied, summarized in Table 2.7.211 
By varying the designing and composition of metals, the geometry and implant methods 
are different. Although the metallic stents has high initial success rate of 90%, they have 
problems in thrombotic closure and restenosis.212, 213 The cause of thrombosis is either 
due to the biological response of the positively charged metallic stents in contact with 
negatively charged blood or owing to the high surface tension of metallic stents. 
Moreover, the mismatch in mechanical behavior between the stent and vessel wall can 
also results in excessive intimal proliferation.214 The problem in metallic stents have 
encouraged to the development of new type of stent to decrease the thromobogenicity of 
stents, such as metallic stents coated with polymers or temporary metallic stent. Much 





Table 2.7 Intracoronary metallic stents.211 
 
Name of stents Composition  Deployment method 
Gianturco-Roubin  Stainless steel Balloon-expansion 
Palmaz-Schatz Stainless steel Balloon-expansion 
Strecker Tantalum Balloon-expansion 
Wiltor Tantalum Balloon-expansion 
Nitinol Titanium-nickel Self-expansion 
Walls tent Stainless steel Self-expansion 
Z stent Stainless steel Self-expansion 
 
2.12.2 Polymer ic stents 
The polymeric stent is potentially useful, and it can be prepared from various 
monomers units. The stent can be controlled to get the smooth surface which will reduce 
the activation of the blood coagulation, thus resulting in the decrease in neointial 
hyperplasia. According to the stability of polymers under physical conditions, polymeric 
stents can be divided into two categories: biostable and biodegradable polymeric stents. 
 
2.12.2.1 Biostable polymer ic stent  
A self-expandable stent and a self-expanding braided mest stent made of 
polyethylene terephthalate (PET) were reported.211 Although PET stent had the 
necessarily mechanical properties and the deployment of PET stents was technically 
feasible, intense inflammatory and neointimal proliferative response were caused by the 
stents, leading to the vessel occlusion.  
 




 Biodegradable polymeric stents have two functions: i) it can remain for a desired 
period to keep the vessel wall; and ii) it is able to be degradaded to non-toxic products 
after completion of the functions. PLLA, PCL and chitosan are the most promissing 
biodegradable polymers for stents.  
PLLA stent 
 The first biodegedable PLLA stent was reported by Agrawal in 1992.215 This stent 
was feasible in deployment and able to maintain the function. More importantly, no 
significant inflammatory and thrombotic occlusions were observed. In recent years, self-
expandable stents have been introduced because of their unique property. The first self-
expandable polymeric stent was made from PLLA, named as Igaki-Tamai stent.37 
However, the self-expansion of this stent was achieved by balloon-expansion at 70 oC, 
which may cause some trauma to cells during the deployment. With the incorporation of 
elastic memory, stents made from the copolymer of PLLA and PLGA was achieved self-
expansion at 37 oC with about 8 min.40, 216 Base on its mechanical properties and in vivo 
assessment, PLLA is a very promising candidate for use as biodegradable polymeric 
stents. However, the time for self-exposition may still be shortened to avoid the 
migration after deployment. 
Chitosan stent 
 Chitosan was also selected for the stents application due to its biocompatibility, 
elasticity and antimicrobial activity. The self-expandable chitosan stent was prepared 






Another promising biodegradable polymer for stent application is PCL. For example, 
PCL stent was reported to achieve expansion by expanding balloon, and the stent was 
able to be shaped to suit the vessel wall, the bile ducts or bronchial tree. However, no 
self-expandable PCL stents were reported so far.  
Polymeric stents have many advantages over metallic stent, such as a better fit 
against the arterial wall, the decreasing in neointimal hyperplasia and thrombosis. 
However, polymeric stents have their limitations. For example, polymeric stents may 
result in extensive fibromuscular proliferation, mononuclear and eosinophilic cell 
infiltration and medial necrosis leading to eccentric stenosis. Thus, it is necessary to 
incorporate drugs into polymeric stent to improve tissue response. 
  
2.12.3 Drug-eluting stents 
Over the past years, the treatment of coronary artery disease has made significant 
progress with the development of percutaneous transluminal coronary angioplasty 
(PTCA).217 Nevertheless, PTCA also causes restenosis of treated arteries resulting in 
abrupt or chronic closure. 33, 218, 219 To overcome this side effect, bare-metal stent (BMS) 
was developed and proved for the treatment of threatened vessel closure after failure with 
PTCA.34-36, 220, 221 However, BMS may cause neointimal hyperplasia leading to in-stent 
restenosis.34-36 To overcome this side effect, drug-eluting stent (DES) was developed, 
which was made from BMS by coating with nonresorbable polymer for drug loading.41 
DES could inhibit vascular smooth cell migration and proliferation with the locally 
released drug.222-227 
For the first generation of DES, drugs were loaded on nonresorbable polymer 




migration and proliferation. DES was approved for use in Europe in 2002, which was 
also approved by FDA in 2003 and 2004 for sirolimus-eluting stents and paclitaxel-
eluting stents, respectively. In spite of the effectiveness of DES in reducing restenosis, it 
simultaneously caused the inflammatory reaction and inhibited the healing of vessel wall, 
thus leading to the thrombogenesis.228-230 Subsequent researches indicated that the 
existence of non-degradable polymer coating may continue to incite a local inflammatory 
reaction and caused thrombogenesis.226, 231 There might be a solution with the advent of 
biodegradable polymeric stents. A few studies have been shown the feasibility and safety 
of biodegrable polymeric stent in vivo. It has also been pointed out polymer-based drug-
eluting stents may be superior to nonpolymer-based stents in the treatment of De Novo 
coronary lesions. 
 
2.12.3.1 Paclitaxel-eluting stent 
The most presently available paclitaxel-eluting stents systems are based on stent 
surfaces coated with drug containing biodegradable or non-biodegradable polymers, such 
as poly(ethylene carbonate)232, poly(vinyl alcohol)-g-poly(lactide-co-glycolide)233 and  
poly(caprolactone)234. Although, polymer coating of coronary stents enables sufficient 
loading and release of incorporated drugs, it also had potentially negative side. With the 
advent of biodegradable polymeric stent, the only example of sirolimus-eluting stent was 
reported to be made from chitason copolymers. However, this stent needed more than 2 
min for self-expansion and showed extremely fast drug release (over 50%) in the first 2 
days.43 Considering the relatively long degradation time and more hydrophobic property 
of PCL, it might be more suitable for lipophilic drug. Thus, drug-eluting stent prepared 




CHAPTER 3 MATERIALS AND CHARACTERIZATION 
METHODS 
 
3.1 Mater ials 
 Novozyme 435 (immobilized Candida Antarctica lipase B, 10000PLU/g) 
(CALB) was brought from Novozymes. ε-Caprolactone (99%), N, N-dimethylformamide 
(DMF, 99%) and 1,4-dioxane (99.8%) from Aldrich were dried with CaH2 for 24 h and 
freshly distillated before use. Glycerol (>99%) (Aldrich) was dried by azeotropic 
distillation in toluene before use. Ethylene glycol (99% Merck) was dried with anhydrous 
Na2SO4 for 24 h and distillated before use. Methylene diphenyl 4,4'-diisocyanate 
isocyanate (MDI) (Aldrich), 1,6-hexanediol (HD) (Aldrich), Novozym 435 and PHBV 
were dried in vacuum oven for 12 h at 40 oC.  m-CPBA (70% Aldrich) was washed 
phosphate buffer (7.5, 1.0M), extracted by dichloromethane and dried by anhydrous 
Na2SO4. 1,4-cyclohexanedione (98%), stannous octoate (98%) and dibutyltin dilaurate 
(95%) were from Aldrich and used as received. All other solvents were purchased from 
Fisher and used as received. 
 
3.2 Mater ial synthesis  
3.2.1 General procedure for  the preparation of three-arm PCL-tr iols 





Novozym 435, ε-caprolactone, glycerol, and dioxane were added into a dried 
Schlenck tube with a magnetic stirring bar. The mixture was stirred at 70 oC under argon.  
After polymerization, the reaction was stopped by adding chloroform. Novozym 435 was 
separated by filtration, and chloroform was removed by evaporation under reduced 
pressure. The crude product was dissolved into chloroform and precipitated in a mixture 
of chloroform and methanol (1:5) at -20 oC. The product was collected by filtration and 
dried in vacuum oven at 40 oC for 24 h. 
 
3.2.1.1 Preparation of three-arm PCL-tr iols (Tm of 47 oC, Mn of 4200 g/mol) 
Novozym 435 (2.06 g), ε-caprolactone (20 mL), and glycerol (0.55 g) were added 
into a 250 mL 2-necked reaction tube with a magnetic stirring bar. The reaction was 
carried out in 1,4-dioxane (60 mL) at 70 oC under argon. After 3 h polymerization, the 
reaction was stopped by adding chloroform (50 mL). Novozym 435 was removed by 
filtration, and 1,4-dioxane as well as chloroform was removed by evaporation under 
reduced pressure. The raw product was dissolved in chloroform (15 mL) and precipitated 
by adding methanol (75 mL) for 12 h. The product was collected by filtration and dried 
under vacuum oven at 40 oC for 24 h. This gave 11.4 g (55% yield) of PCL-Triol. The 
three-arm structure was confirmed by 1H and 13C NMR. Mn was determined by GPC as 
3,200 g/mol and calculated by 1H-NMR analysis as 4,200 g/mol. Tm of 47 oC was 
obtained from DSC curve, and Xc of 64% was calculated based on data from DSC. 
 
3.3 Character ization of mater ials 




3.3.1.1 Gel Permeation Chromatography (GPC) 
The analysis of molecular weight (Mn and polydispersity index Mw/Mn) was 
performed by GPC using a Waters instrument, with Waters 510 pump, Waters 410 
refractive index detector, and Waters HR4E, HR5E and HR6 columns placed in series. 
THF was used as the eluent at a flow rate of 1.0 mL/min at 30 °C for analyzing PCL-
triols. DMF containing 0.05 M LiBr was used as the eluent at a flow rate of 1.0 mL/min 
at 55 °C for the analysis of tPCL-PUs. Sample concentration was about 0.1% (w/v) and 
the injection volume was 100 μL. Polystyrene standards with Mn of 370, 2970, 13900, 
30200, 197000 and 696000 g/mol were used to generate a calibration curve.   
 
3.3.1.2 Nuclear  Magnetic Resonance (NMR) 
1H NMR (500 MHz) and 13C-NMR (125 MHz) spectra were recorded with a 
Bruker AMX500 NMR instrument. Chemical shifts were referred to TMS at 0 ppm. 
 
3.3.2 Character ization of thermal proper ty  
3.3.2.1 Differential Scanning Calor imetry (DSC) 
The thermal properties of polymers were measured on a Mettler Toledo DSC 822 
system. Nitrogen was used as purge gas with a flow rate of 20 mL/min. Samples were 
heated from -20 °C to 180 °C with a heating rate of 20 °C/min, cooled down to -100 °C 
with a cooling rate of -20 °C/min, and then heated again to 180 °C at the same heating 
rate. For analyzing tPCL-PUs, samples were heated from -20 °C to 250 °C, cooled down 
to -100 °C, and heated again to 250 °C at the same heating and cooling rate as that used 
for the analysis of other products. Tm was determined from the second heating curves, 




3.3.3 Character ization of mechanical and shape-memory proper ties  
3.3.3.1 Tensile Stress Test 
The polymer film with a dog bone-shape specimen [50 mm (length) × 3.14 mm 
(width) × 0.2~0.3 mm (thickness)] was used for the tensile stress test by using Universal 
Tester 5569 at 25 oC with a 100N load cell at a deformation rate of 5 mm/min.  
 
3.3.3.2 Collapsed pressure 
The collapsed pressure of the stent was conducted by using compression on 
Microforce Tester Instron 5569. The stent was incubated in phosphate buffered saline 
(PBS) buffer for 1 days at 37 oC and taken out to immediately perform compression test.  
 
3.3.3.3 Shape-Memory Properties 
The shape-memory properties were quantified by the cyclic thermomechanical 
tensile test on Microforce Tester Instron 8848 equipped with thermochamber and 
temperature controller. The testing was carried out in four steps: 1) elongation to εm of 
100% (for tPCL-PU and PCTBVs) or 150 % of PCTOPDs under a tensile load at 65 °C, 
2) cooling to -15 °C while keeping εm at 100%, 3) unloading at -15 °C and holding for 15 
min, and 4) heating of sample to 40 °C. The strain-stress curve was recorded, and the 
cycle was repeated 3 times. From the curve, the strain in the tensile-free state (εu), the 
residue strain after recovery (εp), and the maximum strain during the test (εm) were 
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, where N denoted the Nth cycle. 
 
3.3.4 Cell culture, cytotoxicity, and biocompatibility of materials 
The procedure of cell culture and cytotoxicity experiments was conducted 
according to the literature235. L929 mouse fibroblasts were cultivated in DMEM 
containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin. L929 cells 
were harvested from culture by incubating in trypsin solution (0.5% w/v in PBS) for 15 
min, and centrifuged to take the precipitant. The remained trypsin was neutralized by 
adding serum-supplemented DMEM (3 mL). Cells were then resuspended in serum-
supplemented DMEM with a concentration of 2×104 cells/mL, and cultivated at 37 oC 
and 5% CO2. The biocompatibility of polymer films was evaluated by in vitro 
cytotoxicity tests on the extracts of the polymer films.  Sterilized films were cut into discs 
with a diameter of 8 mm and incubated with the complete culture medium in the ratio of 
6 cm2/mL between the surface area of the material and the volume of extraction vehicle. 
The extracts from the films were diluted to volume ratio of 1:0, 1:1, 1:4, and 1:8 by using 
the culture medium.  Cells were seeded at a density of 3×104 cells/mL into a 96-well 
plate containing 100 uL of the respective extracts, where cells cultivated the culture 
medium were served as negative controls. The plate was incubated at 37 oC in a 
humidified 5% CO2 atmosphere. After three days, a solution of 3-(4,5-dimethylthiazol-2-




was added to each well. After 2 h of incubation at 37 oC, the absorbance of the product 
was measured at 492 nm using a spectrophotometer (TECAN SpectrofluorPlus).  
 
3.3.5 Evaluation of SMPs as self-expandable stent 
The film of SMPs prepared as above was cut into strips with 10cm in length and 
1mm in width. The film was initially wound on a metallic cylindrical rod (diameter of 
3.00 mm) and fixed by an adhesive tape, kept at 55 or 60 oC for 15 min, and cooled down 
to -20 oC for 15 min. The outer diameter of stent was measured. The stent was placed at 
room temperature for 30 min after removing mechanical force, and its outer diameter was 
determined. The stent was then deformed and fixed on a metallic cylindrical rod 
(diameter of 1.00 mm), following the same procedure described above. The outer 
diameter of the stent before and after removing the force was recorded. The stent was 
then put into water bath at 37 oC, and the outer diameter change was recorded by a highly 
accurate CCD micrometer. 
 
3.3.6 Preparation drug-eluting stent and drug release profiles 
Paclitaxel (3.0 wt%) was blended in PCTOPD solution, which was then casted on 
PTFE plate to for the film. The film was subsequently used for the fabrication of drug-
eluting stent. The paclitaxel- eluting stent was finally immersed into sterilized PBS (10 
mL) in a tube, which was incubated in a water-bath shaker at 37 oC at 120 rpm. At each 
data point, the PBS was collected and added a fresh one. The released paclitaxel amount 
was quantified by high-performance liquid chromatography. The concentration of 




column (4 x 125 mm), UV detection at 210 nm, flow rate of 1 mL/min; eluent A, 




CHAPTER 4 SYNTHESIS AND CHARACTERIZATION OF 
THREE-ARM POLY(ε-CAPROLACTONE)-BASED 
POLY(ESTER-URETHANES) WITH SHAPE-MEMORY 
EFFECT AT BODY TEMPERATURE 
 
4.1 Introduction 
Shape-memory polymers (SMPs) possess the capability to remember and return to 
the predefined original shape when exposed to external stimulus, such as light51, 52 and 
temperature.2 SMPs have a wide application in biomedical fields146, 236 such as drug 
delivery,237 biosensors and biomedical devices,238 and implant materials.239 Thermally 
induced SMPs are better than shape-memory alloys (SMAs) as implant materials, since 
SMAs have limitations in deformation rate, programming, and degradability.240 The 
development of degradable SMPs as implant materials has become more and more 
important due to the advantages such as minimally invasive surgery and no needs for a 
second surgery to remove implant materials.118 For such application, the switching 
temperature (Ts) should be around body temperature: the temporary shape of the implant 
material can be created by deformation at temperature higher than Ts, fixed at 
temperature below Ts, and finally returned to its original shape when temperature 
becomes higher than Ts after implanted into the human body. 
Thermally induced shape-memory effects can be achieved by using chemically 
cross-linked networks73, 89, 94 or physically cross-linked copolymers.14, 65, 79 The latter 




segment with higher thermal transition stabilizes the permanent shape, while switching 
segment with lower thermal transition fixes the temporary shape. Ts can be either the 
glass transition temperature (Tg)105, 106, 241 or melting temperature (Tm),112, 117 but Tm is 
preferred due to a sharper transition and better shape recovery.24 Polyurethanes (PUs) are 
often used as biodegradable hard segments for their wide variation of mechanical 
properties.242 On the other hand, the selection of appropriate switching segments for 
biodegradable SMPs with Ts around body temperature is a significant challenge. Poly(ε-
caprolactone) (PCL), poly(lactide) (PLA), and polyglycolide (PGC) are three known 
biodegradable polymers in biomedical applications.24, 243, 244 PLA has a Tg of 60 oC, 
which could be adjusted to 35–50 oC by modifying with PGC.114 However, Tg triggered 
shape-memory effect is less preferred, as mentioned above. From this aspect, PCL is a 
better choice as switching segments: it has a Tm of 60 oC,245 and the Tm can be decreased 
by reducing  the molecular weight (Mn).246 PCL-diols with low Mn were used for the 
preparation of thermally induced SMPs.17 In a successful example, low-molecular-weight 
PCL-diols incorporated with a crystallizable hard segment gave a linear block copolymer 
with shape-memory effect at 37–40 oC.123 However, when non-crystallizable PUs were 
used as hard segment, the Ts of the resulting linear PCL–PU copolymers could not reach 
body temperature:50, 117-119 a Ts of 43 oC was achieved by using PCL-diols with a Tm of 53 
oC and a Mn of 2000 g/mol as the switching segment, and no Ts was observed when PCL-
diols with a Tm of 46 oC and a Mn of 1000 g/mol were used, possibly due to the too low 
molecular weight and crystallinity of the PCL-diols.10  
We are interested in preparing star polymers as thermally induced biodegradable 
SMPs. The higher excluded volume of star polymers may improve the shape-memory 




may be easily adjusted to body temperature by the use of a three-arm switching segment 
such as PCL-triols. Comparing to PCL-diols with a Tm of 46 oC, three-arm PCL-triols 
with the same Tm may have sufficiently high Mn and good crystallinity to give a Ts around 
body temperature for the corresponding star SMP. 
Here we report the enzymatic syntheses of three-arm PCL-triols with well-defined 
structure, controlled molecular weight, and desired thermal properties. PCL-triol was 
prepared by ring-opening polymerization of caprolactone with glycerol as initiator and 
lipase as catalyst. The prepared PCL-triol was then reacted with 4,4'-methylenediphenyl 
diisocyanate (MDI) to form PCL-triol-MDI prepolymer which was finally connected 
with 1,6-hexanediol (HD) to give three-arm PCL-based poly(ester–urethanes). The 
polymers structure, thermal, and mechanical properties, and the investigation of shape-




4.2 Exper imental Section 
4.2.1 General procedure for  synthesis of three-arm PCL-based 
poly(ester -urethane)s (tPCL-PUs).  
Dry MDI in DMF and dibutyltin dilaurate were added in a 3-necked round bottle 
equipped with mechanical stirrer, and a solution of PCL-triols (experiment details refer to 
chapter 3 on page 49, Table 4.1) in DMF was added dropwise. The mixture was stirred at 
65 oC under argon for 6 h. Another portion of dibutyltin dilaurate was added, followed by 
dropwise addition of a solution of HD in DMF. The mixture was stirred at 65 oC for 
another 6 h. Reaction conditions were summarized in Table 4.2. After the reaction, the 
hot viscous solution was poured into methanol (1:2 v/v) and magnetically stirred for 1 h 
at room temperature. The tPCL-PUs were precipitated, collected by filtration, washed by 
DMF/methanol (1:2 v/v) mixture solution three times, and dried in a vacuum oven at 80 
oC for 24 h. 
 
4.2.2 Preparation of three-arm PCL-based poly(ester -urethane) (tPCL-
PU) containing 75wt%  PCL (sample M). 
According to the general procedure for tPCL-PUs synthesis, MDI (0.51 g) in 
DMF (15 mL) and dibutyltin dilaurate (40 mg) were added in a 250 mL 3-necked round 
bottle equipped with mechanical stirrer. A solution of PCL-triol (Sample D, 2.0 g) in 
DMF (30 mL) was added dropwise at 65 oC. After 6 h polymerization, dibutyltin 
dilaurate (20 mg) and a solution of HD (0.16 g) in DMF (10 mL) were added. The 
reaction was continued at 65 oC for another 6 h. After reaction, the mixture was poured 




by filtration and washed by DMF/methanol (1:2, 60 mL) three times. After drying in 
vacuum oven for 24 h at 80 oC, 2.2 g (83%) of tPCL-PU was obtained. The polymer 
structure was confirmed by 1H NMR, and Mn was deduced as 6,800 g/mol by NMR 






4.3 Results and Discussion 
4.3.1 Enzymatic synthesis of three-arm PCL-tr iols.  
Synthesis: Previously, it was found that the Ts of PCL-based linear block 
copoly(ester-urethanes) was about 10 oC lower than the Tm of PCL-diols used as starting 
materials.118 Therefore, we target at the preparation of three-arm PCL-triols with a Tm of 
45-48 oC to achieve a Ts of body temperature for the corresponding star SMPs. PCL-triols 
was previously synthesized by stannous octoate-catalyzed ring-opening polymerization 
(ROP) of ε-caprolactone with glycerol as initiator.247 However, it was difficult to obtain 
PCL-triols in pure form, and the prepared PCL-triols mixture showed more than one 
Tm.247  On the other hand, enzyme-catalyzed reactions are often highly selective, and 
enzyme-catalyzed ROPs have been well established.34-40 Therefore, we explored the 
enzymatic ROP of ε-caprolactone (CL) with glycerol (G) as initiator to prepare three-arm 


























Scheme 4.1 Synthesis of three-arm PCL-triols via enzyme-catalyzed ROP of ε-
caprolactone with glycerol 
 
Novozym 435 [immobilized Candida Antarctica lipase B (CALB)]248-251 was 
chosen as the enzyme for the target ROP, since it is well-known for high catalytic 
activity, good solvent resistance, and high stability for this type of transformation.252, 253 




Novozym 435.38-40 1,4-Dioxane was used as solvent due to the good solubility for both 
starting materials and product. To avoid water-initiated ROP, anhydrous system under the 
protection of argon atmosphere was utilized. Different reaction conditions including the 
ratios of CL/G, CL/E, CL/Sol, and reaction time were investigated to synthesize PCL-
triols with a Tm of 45-48 oC. The reactions were followed by GPC analysis of samples 
taken at different time points. PCL-triols were separated from the immobilized enzyme 
by filtration, precipitated in a mixture of chloroform and methanol (1:5) at -20 oC, and 
dried in vacuum oven at 40 oC. The yields were 50-86%. The reaction conditions and 
results were summarized in Table 4.1. 
Table 4.1 Novozym 435-catalyzed ROP of ε-caprolactone with glycerol at 70 oC 



























1 10:1 10:1 N.Sf 1.5 67 2700 2720 1.56 (40)g 
45 
55 A 
2 10:1 10:1 1:2 4 86 2900  1.46 46 
(50)g 
57 B 
3 30:1 10:1 1:2 3 72 4900 5600 1.42 53 68 C 
4 30:1 10:1 1:3 3 55 3200 4200 1.38 47 64 D 
5 30:1 10:1 1:3 2 50 3000  1.35 46 61 E 
a CL for ε-caprolactone, G for Glycerol. b E for Novozym 435. c Sol for solvent, Dioxane. 
d Xc was calculated according to the equation: ( ) %100%100 ×∆∆= HHX mc , where 
∆H100% is the theoretical heat of fusion of PCL (135 J/g). e Mn was determined by GPC 
with polystyrene as standards in THF. f N.S for no solvent. g Shoulder near the major 
melting peak in the DSC curve. 
 
In Entry 1 and 2, the ratio of CL/G and CL/E were all fixed at 10:1, while bulk 
and solution polymerization were compared. In both cases, Mn of the product increased 




triols with a Mn of 2,700 g/mol (GPC) at 1.5 h, whereas solution polymerization gave the 
product with a Mn of 2,900 g/mol at 4 h. Obviously, the ROP in dioxane was slower, thus 
being more easily controlled to obtain desired PCL-triols. Moreover, it offered a 
relatively narrow polydispersity of PCL-triols. However, PCL-triols prepared in both 
cases showed a major Tm peak and a shoulder in DSC (curve A and B in Figure 4.1), 
indicating the existence of mixed structures of different types of PCL-triols due to the 
incomplete reaction of three hydroxyl groups in one glycerol molecule with CL. To solve 
this problem, the ratio of CL/G was increased to 30:1 (entry 3-5). Under this condition, 
the effects of ratio of CL/Sol and reaction time on the ROP were studied. In entry 3 and 
4, the reaction time was kept for 3 h while the ratios of CL/Sol of 1:2 and 1:3 were 
compared. In the later case, more solvent was used, which reduced the reaction speed and 
led to a decrease of Mn of PCL-triols from 4,900 g/mol to 3,200 g/mol. On the other 
hand, reduction of the reaction time from 3 h to 2 h (entry 5 vs 4) did not change too 
much the Mn of PCL-triols. All three PCL-triols prepared with a ratio of CL/G of 30:1 
(entry 3-5) showed only a single melting peak in the corresponding DSC curves (Figure 
4.1), with a Tm of 53 oC, 47 oC and 46 oC, respectively. 
















The enzyme-catalyzed ROP of CL with glycerol is much faster than the stannous 
octoate-catalyzed ROP which, for instance, required 48 h to reach polymer Mn of 2,980 
g/mol at the CL/G ratio of 10:1.247 In addition, PCL-triols prepared by using metal 
catalyst showed two Tm even if the ratio of CL/G was increased to 40:l. Therefore, the 
enzymatic ROP was the only choice for the synthesis of PCL-triols with well-defined 
three-arm structure and single Tm.  
The relationship between the Tm and Mn of PCL-triols prepared by enzymatic 
ROP was shown in Figure 4.2. Tm of PCL-triols decreased linearly with the decrease of 
the Mn. The desired Tm of 46-47 oC was observed in the PCL-triols with a Mn of 3,000-
3,200 g/mol (GPC). In comparison, linear PCL-diols with a Tm of 45.8 oC had a Mn of 
only 1,000 g/mol which is too low to show any Tm for the block copoly(ester-urethane) 
prepared with such PCL-diols.10 Obviously, PCL-triols has much higher Mn than PCL-
diols at the same Tm  (46-47 oC). This is very important, since the increased molecular 
weight of PCL-triols could promote the crystallization of PCL switching segment in the 
corresponding SMPs to show the melting point. The crystallinity of PCL-triols was 
estimated based on the enthalpy determined by DSC and the theoretical heat of fusion of 
PCL (135 J/g).41 PCL-triols with Tm of 46-47 oC and Mn of 3,000-3,200 g/mol had Xc of 
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Figure 4.2 The dependence of the Tm and Xc on the Mn of PCL-triols. 
 
Structure Analysis: The chemical structure of all PCL-triols was determined by 
NMR analyses in DMSO-d6 at 333 K. 1H and 13C NMR spectra of PCL-triols (sample D) 
with Tm of 47 oC and Mn of 3,200 g/mol (GPC) were shown in Figure 4.3 and 4.4, 
respectively. In the 1H NMR spectrum, each signal could be assigned to the 
corresponding proton of the proposed structure of three-arm PCL-triols (Figure 4.3). 
There are three OH groups in glycerol, and the disappearance of OH signals (4.70 ppm) 
from glycerol indicated the reaction of OH groups with CL. If part of OH groups was not 
reacted, it could form a mixture of mono-, di- and tri-esters of glycerol with H-(1) signal 
in three different regions, 5.22-5.32, 5.02-5.12 and 4.91-4.99 ppm.247 For sample D, H-
(1) signal appeared in the region of 5.05-5.12 ppm, suggesting a pure tri-ester structure. 
H-(7’) of CH2-OH end group of PCL-triol absorbed at 3.35-3.51 ppm, and other protons 
of PCL repeating unit such as H-(3-7) were observed in the corresponding area indicated 
in Figure 4.3. Based on this analysis, the structure of the product sample D was the 
proposed three-arm PCL-triols in Scheme 4.1. From the intensity of signal H-(7) and H-




was deduced as 4,200 g/mol, which was comparable with the Mn determined by GPC 












































Figure 4.3 1H NMR spectrum of PCL-triols (sample D) in DMSO-d6 at 333 K. 
 
The structure of three-arm PCL-triols was further confirmed by 13C NMR 
analysis. As shown in Figure 4.4, all signals could be assigned to the carbons of PCL-
triols. The signal intensity for the repeating unit [C-(c-h)] was much higher than that for 
the terminal carbons [C-(c’-h’)]. The carbon C-(h’) of the end group CH2-OH was clearly 
















































~ ~ ~ ~e’
e
 
Figure 4.4 13C NMR spectrum of PCL-triols (sample D) in DMSO-d6 at 333 K. 
 
4.3.2 Preparation and structure analysis of three-arm PCL-based 
polyesterurethanes (tPCL-PUs).  
Synthesis: Three-arm PCL-triols with Tm of 45 oC (sample A), 47 oC (sample D), 
and 53 oC (sample C) were used for the preparation of the corresponding three-arm PCL-




shown in scheme 4.2. In step 1, PCL-triol was reacted with methylene diphenyl 4,4'-
diisocyanate isocynate (MDI) using dibutyltin dilaurate as catalyst and the reaction was 







































































































Scheme 4.2 Synthesis of tPCL-PU from PCL-triols, MDI, and HD via two-step reactions 
 
avoid the possible crosslinking, a dilute PCL-triols in DMF solution were very slowly 
added into a concentrated DMF solution containing MDI in excess. Moreover, the ratio 
of MDI/PCL-triols between 4.3:1 and 7.1:1 was used, which is larger than the ratio at 
equivalent of 1.5:1 for the reaction step 1. In step 2, 1,6-hexanediol (HD) and some 
dibutyltin dilaurate in DMF was added to the mixture of step 1, and the reaction was 




remaining MDI after the reaction step 1. As listed in Table 4.2, different feed ratio of 
PCL-triols/MDI/HD was applied to prepare the final polymer with 55-80% switching 
segment. After the polymerization, the reaction mixture was poured into methanol, and 
product was precipitated. To remove the possible cross-linking product, the solid material 
was re-dissolved in DMF and filtrated. The filtration solution was precipitated in 
methanol. The polymer (tPCL-PUs) was dried in vacuum oven overnight to give a non-
sticky solid material, with an over yield of 70-95% for two-step syntheses.  
Table 4.2 Synthesis of tPCL-PU by polymer ization of PCL-tr iols, MDI, and HD with 





















1 A 1.0 : 7.1 : 5.6 55 F 95 43,700 N.T.d   
2 1.0 : 6.1 : 4.6 60 G 95 32,600 N.T.d   
  3  1.0 : 4.6 : 3.1 65 H 92 24,600 38 -46 19 
  4 1.0 : 4.0 : 2.5 70 I 85 18,400 36 -46 22 
  5 1.0 : 3.2 : 1.7 75 J 80 13,100 38 -45 28 
6 D 1.0 : 6.6 : 5.1 65 K 90 26,200 39 -43 22 
7 1.0 : 5.4 : 3.9 70 L 85 19,500 38 -42 31 
8 1.0 : 4.2 : 2.7 75 M 83 13,900 38 -42 33 
  9 C 1.0 : 7.0 : 5.5 70 N 88 19,600 48   
  10 1.0 : 4.3 : 2.8 80 O 70 14,200 50   
a The polymerization consists of two steps: 1) PCL-triols was reacted with MDI in the 
presence of dibutyltin dilaurate in DMF at 65 oC for 6 h; 2) HD and dibutyltin dilaurate 
were added and the reaction continued at 65 oC for 6 h. b SS for soft segment of tPCL-PU; 
the percentage was calculated based on the feed ratio. c Mn was determined by GPC with 
polystyrene as standards in DMF with 0.05 M LiBr at 55 oC. d N.T. for no Tm . 
 
Structure Analysis: All tPCL-PUs were characterized by 1H NMR analysis. The 
spectra of the intermediate after reaction step 1 and final product tPCL-PU (sample M) 
from entry 8 of Table 4.2 were shown in Figure 4.5 and 4.6, respectively. The 




methanol, filtrating, and drying in vacuum oven. In the 1H spectrum of the intermediate, 
the peak at 3.36 ppm corresponding to H-(7’) of the end group (–CH2-OH) from PCL-
triols (Figure 3.3) disappeared, and a new peak in the range of 4.03-4.09 ppm was 
observed for H-(7’) due to the transformation of the ending group (–CH2-OH) into –CH2-
OR via the reaction with MDI. Moreover, a peak at 9.23 ppm corresponding to NH-(a) 
group was observed, which further indicated that the reaction happened between PCL-
triols and MDI. Based on the three-arm structure, the theoretical ratio of H-(3,3’)/NH-(a) 
should be 26, calculated from 2(n+1)/1 with n of 11.7. The ratio of H-(3,3’)/NH-(a) was 
determined as 29.9 from Figure 4.5, which was very close to the theoretical value. This 
suggested the three-arm structure of the intermediate after reaction step 1. During the 
preparation of intermediate sample, unreacted MDI were also precipitated in methanol, 
thus existing in the intermediate sample. Therefore, H-(b, c, d) could not be used for the 
structure analysis.  
In the 1H NMR spectrum of tPCL-PU sample M in Figure 4.6, the ratio of peak at 
9.23 ppm for NH-(a) and those for H-(b,c,d) was much bigger (nearly 1:2) than that in 
Figure 4.5, which indicated that the reaction in step 2 happened. The number of repeating 
units (m) in the hard segment (MDI+HD) could be calculated based on the intensity of 
NH-(a) and H-(3,3’). The ratio of NH-(a)/H-(3,3’) should be m/12.7, and ratio of the 
signal intensity was determined as 0.19:1 from Figure 4.6. Therefore, m was established 
as 2.4. The intensity of signals at 1.2-1.47 ppm for H-(5,5’,10,11), 1.5-1.7 ppm for H-
(4,4’,6,6’,9,12), and 3.95-4.08 ppm for H-(7,7’,8,13) related to that at 2.2-2.4 ppm for H-
(3,3’) was increased in comparison with those in Figure 4.5. This further confirmed the 
taking place of the reaction in step 2. In Figure 4.6, the ratio of the signals at 1.2-1.47 




signals at 1.2-1.47 ppm for H-(5,5’) and 2.2-2.4 ppm for H-(3,3’) in Figure 4.5 for the 
intermediate is 1.06:1. Thus, the signal ratio of H-(10,11)/H-(3,3’) for the tPCL-PU is 
0.34:1. This value equals to (2×m)/12.7, giving rise to m of 2.2 which was nearly the 
same as the above established value. Mn of the polymer was thus deduced to be 6,600 
g/mol. This is comparable with the Mn of 5,600 g/mol for a three-arm polymer estimated 
based on the feed ratio of the reactants and the Mn (4200, NMR) of PCL-triols used. 
Thus, the NMR analysis supported the three-arm structure of tPCL-PUs in scheme 4.2. 
The Mn of all polymers was also analyzed by GPC, but the values obtained are not 






























































Figure 4.5 1H NMR spectrum of PCL-MDI, an intermediate after reaction step 1 for the 
preparation of tPCL-PU (sample M) in DMSO-d6 at 333 K (Signal* existed also in the 1H 





























































































Figure 4.6 1H NMR spectrum of tPCL-PU (sample M) in DMSO-d6 at 333 K (Signal* 
existed also in the 1H NMR spectrum of pure MDI). 
 
4.3.3 Thermal proper ties of tPCL-PUs.  
The thermal transitions of tPCL-PUs were determined by DSC, the curves from 
the second heating run were shown in Figure 4.7, and Tm, Tg, and Xc were listed in Table 
4.2. tPCL-PUs containing 65-75% PCL-segment derived from PCL-triols (sample A or 
D) with a Tm of 45-47 oC showed a Tm of 36-39 oC, thus reaching the desired and 
designed switching temperature. On the other hand, the use of PCL-triols with Tm of 53 
oC (sample C) as switching segment gave the corresponding polymer with a Tm between 
48-50 oC, even with 80% switching segments. In general, Tm of tPCL-PUs was lower than 




inhibited crystal formation via the incorporation of hard segment. Tm was also dependent 
on the percentage of switching segment in the polymer: using the same PCL-triols 
(sample A), tPCL-PUs contains lower than 60% PCL-segments did not show any Tm. 
From DSC curves, a clear Tg between -46 oC and -42 oC was observed for all tPCL-PUs 
with a Tm of 36-39 oC. For comparison, PCL-triols did not show any Tg. Thus, the 
incorporation of PCL with hard segment makes Tg detectable. 












Figure 4.7 DSC spectra of tPCL-PUs (sample H-O) from second heating. 
 
4.3.4 Mechanical and shape-memory proper ties of tPCL-PUs.  
The mechanical property of tPCL-PUs was examined by tensile tests at 25 oC and 
60 oC, and the results for sample J and M are given in Table 4.3. In both cases, Yong’s 
modulus (E), tensile strength at maximum (σm), and  elongation at break (εR) were higher 
at higher temperature: while E of 18-23 MPs, σm of 10-12 MPa, and εR of 229-357% 
were observed at 25 oC, E, σm, and εR decreased to 3.9-4.6 MPa, 3.6-4.4 MPa and 143-

























25 oC      60 oC      
J 18±3.5 229±20.4 10±0.5 3.9±0.1 143±12.0 3.6±0.4 
M 23±2.7 357±17.6 12±0.8 4.6±0.3 272±14.1 4.4±0.2 
a E for Yong’s modulus. b εR for elongation at break. c σm for tensile strength at maximum. d 
N(x) for cycle x in the cyclic thermomechanical tensile tests. The mean values of E, εR, 
and σm were obtained from three measurements. 
 
As an example, the shape deformation and recovery process for tPCL-PU sample 
M was shown in Figure 4.8. The sample was first stretched to the deformed state at 60 oC, 
the temporary shape was then fixed at 5 oC, and finally the temperature was raised to 38 
oC to recover the original state. The shape-memory behavior was clearly observed. 
 
 
Figure 4.8 tPCL-PU (sample M) showing shape memory effect at 38 oC: (a) initial state; 
(b) deformed state (stretched at 60 oC and fixed at 15 oC); (c) recovered state after 10 s 
(soaked into 38 oC water). 
 
 
To further quantify shape-memory properties, samples were analyzed by cyclic 
thermomechanical tensile tests. Stress-strain curves in the first cycle for tPCL-PU 




heated to 60 oC for 5 min, and stretched to extension of 100 % (εm) by applying a 
deformation stress (step 1). εm was correspondingly recorded; It was then cooled down to 
15 oC while keeping the strain under constant εm, and a decrease in stress was observed 
(step 2); The stress was unloaded, and the temporary shape was fixed after release the 
stress (step 3). εu was recorded;  Finally, the sample was heated to 38 oC, and the original 
shape was quickly recovered in about 10 s (step 4). εp was recorded. The shape recovery 
rate (Rr) and shape fixity rate (Rf) in the first cycle could be calculated as 95% and 91% 
based on the equation: ( ) ( )[ ] %1001 ×−= mpmrR εεε and ( ) ( ) %1001 ×= mufR εε . Sample 
K-M from PCL-triols with Tm of 47 oC and Mn of 4200 g/mol showed Rf of 90-91%, 
while sample H-J from PCL-triols with Tm of 45 oC and Mn of 2720 g/mol showed lower 
Rf of 81-84% (Table 4.4) in the first cycle. The increase in molecular weight might of 
PLC segment promote the crystallization and thus increased Rf. However, the increase of 
molecular weight and crystallinity of PCL-triols showed only a small effect on Rr, with 
94-95% for samples K-M and 91-93% for samples H-J. With the increased number of test 
cycles, Rr increased slightly and reached 99% in the third cycle, while Rf was almost the 
same for all three cycles. The percentage of switching segment between 65% and 75% 
had a negligible influence on Rf and Rr in all samples. During the shape-memory 
transition, all tPCL-PUs produced stress in the range of 2 to 3 MPa, which resembles the 
mechanical stresses in soft tissue.30 This suggested that our shape-memory polymer might 












































Figure 4.9 Strain-stress curve of tPCL-PU (sample M) from cyclic thermomechanical 
tensile tests with ε =100%. 
 
Table 4.4 Shape-memory proper ties of tPCL-PU (sample H to M) determined by 








N(1)a N(2)a N(3)a N(1)a N(2)a N(3)a 
H 81 82 82 91 95 98 
I 83 83 84 92 97 99 
J 84 84 84 93 98 99 
K 90 91 91 94 97 99 
L 90 90 91 95 98 99 
M 91 92 92 95 98 99 
a N(x) for cycle x in the cyclic thermomechanical tensile tests. bRf for shape fixity rate. 








Three-arm PCL-triols were developed as biodegradable switching segment for the 
preparation of star polymer with shape-memory effect around body temperature. 
Enzymatic ring-opening polymerization of ε-caprolactone with glycerol as initiator gave 
the corresponding PCL-triols with high purity and good yield. PCL-triols with Tm of 45-
47 oC were obtained by controlling the Mn between 2720 and 4200 g/mol. The three-arm 
structure of PCL-triols was established by 1H and 13C NMR analyses. 
Star SMPs were prepared in high yield by polymerization of PCL-triols with MDI 
and subsequently with HD in the presence of dibulytin dilaurate. The three-arm structures 
of tPCL-PU and its synthetic intermediate were confirmed by NMR analysis. Ts of tPCL-
PUs could be adjusted by using PCL-triols with different Tm. Ts of 36-39 oC was achieved 
by using PCL-triols with Tm of 45-47 oC and Mn of 2720-4200 g/mol. Excellent shape-
memory properties of tPCL-PU were demonstrated in cyclic thermomechanical tensile 
tests at 38 oC, with shape recovery in 10 second, shape fixity rate of 91-92%, shape 
recovery rat of 95-99%. The prepared three-arm biodegradable shape-memory polymers 





CHAPTER 5 BIODEGRADABLE SHAPE-MEMORY 
POLYMER AS FAST SELF-EXPANDABLE STENT 
 
5.1 Introduction 
Thermally-induced shape-memory polymers (SMPs) are smart materials able to 
change shapes when responsive to temperature change.18, 70 They have attracted much 
attention in biomedical application such as implantations.8, 146 The use of biodegradable 
SMPs as implants combines multi-functions, such as shape-memory effect at body 
temperature to actuate the shape change after insertion into the human body for 
minimally invasive surgery, and biodegradability to avoid a second surgery for implant 
removal.254 Some SMPs have been made as sutures 123 and wound healing materials 255, 
256. In principle, SMPs could also be useful for another highly desirable application, the 
biodegradable stent with self-expandability. However, no such example has been 
reported. Currently, the known biodegradable stents are the Igaki-Tamai (PLLA)37, 
PLLA/PLGA40, and chitosan stents38, 39. Although the last two could achieve self-
expansion at 37 oC which is higher than the Tg of the polymer, the fastest expansion time 
obtained so far is 2.5 min 37-40, 257, 258. As a very important parameter, the self expansion 
time of stents should be ideally less than a minute40, since a fast self-expansion benefits 
the in vivo deployment and prevent migration after insertion. The slow expansion of 
PLLA/PLGA and chitosan stents is caused by Tg-based expansion which possesses a 
board change range. A Tm-based polymeric system could provide a fast and sharp 




biodegradable SMP as self- expandable stent to achieve a fast and complete self 
expansion. 
So far, the Tm-dependent SMPs24 are often linear block copolymers consisting of 
two segments: the switching one for the fixation of temporary shape and the hard one for 
the fixation of the permanent shape2, 259. As for hard segment, non-crystallizable 
polyurethane (PU) is often used 118, 241,14, 112, 117, but with difficulties in traditional thermal 
processing and in adjusting the mechanical property for desired applications. Therefore, 
crystallizable polymer block could be a better choice. In the only known example, 
crystallizable poly(p-dioxanone) was used as hard segment to prepare a biodegradable 
SMP with good application potential as suture123. Regarding to our application as stent, 
we are particularly interested in developing microbial polyester, poly[(R)-3-
hydroxybutyrate-co-(R)-3-hydroxyvalerate] (PHBV), as the hard segment due to its high 
Young’s modules to adjust the mechanical properties, a Tm over 140 oC31 for the 
stabilization of permanent shape, good biodegradability and biocompatibility as well as 
the application as scaffolds260, 261. Thus, PHBV is a good candidate as a desired 
crystallizable hard segment for SMP as stent. On the other hand, the choice of the 
switching segment for SMP should have two requirements: (i) it is responsible for 
controlling the switching temperature (Ts) at body temperature2, and (ii) it is able to 
maintain the flexibility of SMP for stent application because inflexibility of stents may 
result in abrupt closure211. Under this consideration, the most suitable switching segment 
for biodegradable SMPs as stent application is poly(ε-caprolactone) (PCL) because PCL 
is a restorable biomaterial certified by FDA262 and it improves the chain flexibility of 
poly(L-lactide) in their copolymer263. Moreover, our developed three-arm PCL as 




which addressed the problem of the linear PCL as switching segment in SMP that has 
difficulty in reaching a Ts around body temperature and results in relatively low Rf. 
Therefore, the designed SMP for stent application would combine the mechanical 
strength of PHBV, the chain flexibility of ε-caprolactone and Ts at body temperature.  By 
the incorporation of two biodegradable PCL265 and PHBV261 with degradable urethane 
group, the synthesized SMP has no difficulty in degradation.  
In this paper, we report the synthesis and characterization of a series of novel 
SMPs containing three-arm PCL-based switching segment and PHBV hard segment. 
PCL-triol was reacted with 4,4'-methylenediphenyl diisocyanate (MDI) to form 
hyperbranched PCL prepolymer which was then connected with PHBV and MDI to give 
poly(ester–urethanes). Subsequently, the first example of using SMP as self-expandable 
stent is also demonstrated. In addition, the SMP containing three-arm PCL-based 
switching segment is compared with the SMP containing linear PCL-based switching 




5.2 Exper iments 
 5.2.1 Preparation of PHBV-diol. 
In a modified reaction of the known procedure266-268, dry PHBV (10 g) and 
distillated ethylene glycol (15 mL) were added into dry diglyme (40 mL) with dibutyltin 
dilaurate (0.3 g), and the reaction mixture was stirred at 130 oC for 4 h under N2. After 
the reaction, the mixture was poured into water, precipitated and collected. The crude 
product was dissolved in chloroform (10 mL) and precipitated in methanol (50 mL). The 
product was collected by filtration and dried in vacuum oven at 40 oC for 24 h. 7.8 g of 
PHBV-diol was prepared. The structure was determined by 1H NMR and a product with a 
Mn of 2200 g/mol (NMR) as well as a Tm of 137/148 oC was obtained. 
 
5.2.2 Synthesis of poly(PCL-PHBV)urethanes (PCTBV)s.  
In step 1, a mixture of PCL-triol (2 g) and MDI (0.27 g) in dry DMF (10 mL) was 
stirred at 75 oC for 8 h under N2, where the intermediate was taken, washed by methanol 
and dried. The structure of the intermediate was analyzed by 1H NMR. A solution of 
PHBV-diol in dry DMF were added to the reaction mixture of step 1 followed by stirring 
at 90 oC for 44 h. Afterwards, the reaction solution was poured into methanol, and the 
mixtures were stirred for 1 h at room temperature. The product was then precipitated, 
collected by filtration, washed three times with dioxane/methanol, and dried under 
vacuum for 24 h to give PCTBV with 96% yield. The Mn of PCTBV was analyzed by 






5.3 Results and Discussion 
5.3.1 Synthesis of poly (PCL-tr iol/PHBV-diol) urethanes (PCLBVs). 
The linear PHBV-diol (19 wt% PHV) with a Tm of 137/148 oC was also 
synthesized using the known method. The chemical structure of PHBV-diol was 
















Figure 5.1 1H NMR spectrum of PHBV-diol (19%wt PHV) in CDCl3. 
 
Initially, one-step polymerization was applied to produce random copoly(PCL-
triol/PHBV-diol urethane)s (PCTBVl)s, which involves the reaction of PCL-triol, PHBV-
diol, and methylene diphenyl diisocyanate (MDI) in DMF at 90 oC for 44 h. The 
corresponding products (PCTBVls), containing PCL and PHBV blocks at 15 to 50 wt% 




that, the sample was applied for the DSC analysis by heating to 180 oC and isotherm for 2 
mins to remove the thermal history. It was then cooled down to -100 oC and heat again to 
180 oC. The second heating curve was recorded in Figure 5.2. Unfortunately, only a small 
melting peak for Tm of 141 oC for PHBV hard segment was detected and no melting peak 
for three-arm PCL switching segment was observed in DSC curves for all cases. The 
disappearance of Tm in switching segment may be caused by the incorporation of PHBV 
hard segment which decreased the crystallinity of PCL segment. The problem might be 
solved by using PCL-triol with higher crystallinity. However, PCL-triol with higher 
crystalllinity has also higher Mn and Tm, thus increasing Ts above body temperature in the 
corresponding SMP.118 














Figure 5.2 DSC curves for PCTBVs. 
 
Our approach here was to prepare switching segment by linking several PCL-
triols together with MDI to increase the Mn and reduce the decreasing of crystallinity. 
Thus, PCL-triol and MDI in excess were reacted in DMF at 75 oC for 8 h to produce 




linking product, the solid material was re-dissolved in DMF and filtrated. The filtration 
solution was precipitated in methanol.  To investigate the intermediate product (PCTM), 
sample was taken out, precipitated in methanol, and washed with chloroform. The 
obtained PCTM had a Mn of 25400 g/mol determined by GPC and showed a Tm of 38 oC 
and a Xc of 29% in the DSC curve (Figure 5.2). Although the linkage with MDI 
decreased the crystallinity and Tm to some extent, the appropriate Tm value and the 
enough crystallinity make the hyperbranched PCTM as an attractive switching segment 
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The chemical structure of PCTM was analyzed by 1H NMR (Figure 5.3). 
Assuming that there are y PCL-triols linked together in PCTM, the ratio of H-(1)/H-(7) is 
(n +1)× 2×3× y ( y + 2), where n is 10.7 (repeating units of PCL-triol). The signal 
intensity of H-(1)/H-(7) is calculated as 51.28 based on the signal intensity. Therefore, y 
can be deduced as 4.9. y can also be established as 4.8 based on the signal intensity of H-
(5) and H-(7). Moreover, the ratio of H-(6)/H-(7) should be 3y/(y+2), and y can be thus 
obtained as 4.8 based on the signal intensity of H-(6)/H-(7) in Figure 5.3. On average, 
five PCL-triols are linked together via MDI, corresponding to Mn of 23800 g/mol for 
PCTM, which is very close to the Mn obtained from GPC. PCTM was therefore used as 
switching segment for the SMP synthesis. After the first step reaction as described above, 
PHBV-diol at different amount was directly added to the reaction mixture, and the 
second step reaction was performed at 90 oC for 44 h to give a series of PCTBVs with 20-
30 wt% of PHBV in an overall yield of 96%. The molecular weight and thermal 
properties were measured by GPC and DSC, and the results were given in Table 5.1. 
PCTBVs with Mn of 36300 to 65300 g/mol showed Tm of 39-40 oC and Xc of 30-34% for 
three-arm PCL-based switching segment as well as Tm of 140-142 oC for PHBV hard 
segment. PCTBVs showed the similar Tm and Xc as PCTM, independent of PHBV weight 
percent. This confirmed that the incorporation of PHBV segment did not decrease the 
crystallinity of PCL segment. This may be due to the increased molecular weight as well 
as the special dendrimerlike structure of the PCL switching segment. In a word, the 
synthesized PCTBVs have the desired thermal property with two Tm: the low one is 40 oC 
from the switching segment suitable as Ts close to body temperature, and the high one is 

























































































































- - 10500 2300 2200    
PCLTg 100 - 47 67 11000 4000 4100    
PCTM 91 - 38 29 25400  23300    
PCTBV-
20h 71 138 39 30 
3630
0      
PCTBV-
25 66 140 40 30 
4720




27 64 141 40 34 
5240
0      
PCTBV-
30 61 142 40 30 
6530




25i 66 141 N.A N.A. 
5040
0      
PCLDj 100 - 47 71 5600 2100 1400    
PCDM 85 - 38 27.5 26500      
PCDBV-
20k 67 143 39 28 
3880
0      
PCDBV-
25 62 142 40 28.2 
4120
0   660 11.1 42 
PCDBV-
27 59 136 40 28.4 
5240
0      
PCDBV-
30 55 132 40 29.2 
6330
0   550 11.3 60 
PCDBVl-
25i 62 N.A. N.A N.A. 
4600
0      
a Mn was determined by GPC with polystyrene as standards in DMF. b Mn was determined 
by GPC with polystyrene as standards in THF. c Mn was calculated by NMR in d6-DMSO 
at 60 oC. d εb for the elongation at breakage. e σm for maximum tensile strength. f E for 
Young’s modulus. εb, σm and E are determined by tensile test with a deformation rate of 5 
mm/min at 25 oC. The mean values of E, εR, and σm were obtained from three 
measurements. g PCLT for PCL-triol. h PCTBV-20 for poly(PCL/PHBV urethane), and 




were prepared by one-step synthesis.  j PCLD for the PCL-diol. k PCDBV for 
poly(PCL/PHBV urethane).  
5.3.2 Mechanical proper ties of PCTBVs. 
The mechanical properties of PCTBVs were determined by tensile tests on 
Microforce Tester Instron 5569 using films (0.2-0.3 mm in thickness) with a deformation 
rate of 5 mm/min at 25 oC. The maximum tensile strength (бm), the elongation at break 
(εb), and Young’s modules (E) were obtained from stress-strain curves and given in Table 
5.1. All PCTBVs showed εb of 500 to 605%, бm of 11.2 to 14 MPa, and E of 43 to 70 
MPa. The maximum stress of PCTBVs (14 MPa) is comparable to the chitosan stent (~ 
20 MPa)39. However, our products exhibited higher εb, indicating the ductile nature of the 
materials and making them more feasible for the fabrication and in vivo deployment of 
stents. PHBV weight percent slightly influenced the mechanical property of PCTBVs. A 
lower εb, higher бm, and higher E were observed at a higher weight percent of PHBV. 
This confirmed that the incorporation of PHBV could adjust the mechanical property in a 
wide range to meet the requirement of various applications. 
 
5.3.3 Shape-memory proper ties of PCTBVs. 
Shape-memory effect of PCTBV-25, the block-copolymer containing 25 wt% 
PHBV hard segment, was examined by making the film with a permanent shape of rod 
into a spiral at 65 oC, fixing this shape at -15 oC for 15 min, keeping at room temperature 
for 30 min, and then placing in the water bath at 40 oC. As shown in Figure 5.4, the 
temporary shape returned back to the original shape in 25 s. The recovered materials 
were used for further test cycles and demonstrated that PCTBV-25 were able to memory 















Figure 5.4 A series of photographs showing shape memory effect of the film made from 
PCTBV-25 in water bath at 40 oC. (a) Temporary shape (spiral) at 25 oC, (b)-(d) shapes 
in water bath at 40 oC after 5s,12s, and 18s respectively, and (e) shape returning to 
original form (rod) in water bath at 40 oC after 25s. 
 
To further quantify shape-memory property, the cyclic thermomechanical tensile 
test was performed to obtain two important parameter of SMP: the fixity rate (Rf) and the 
recovery rate (Rr). Rf quantifies the ability of shape-memory materials to fix the 
temporary shape in the cooling state, while Rr shows the capacity of materials to recover 
the original shape. In the measurement shown in Figure 5.5, the original shape was first 
elongated to 100% at 65 oC, the temporary shape was fixed under stress control mode by 



























Figure 5.5 Strain-stress curve of PCTBV-25 from cyclic thermomechanical tensile tests 
with εm of 100%. The film was elongated to εm of 100% at 65 oC, cooled down to -15 oC, 
unload while kept at -15 oC, and heated to 40 oC. 
 
From the curve, the strain in the tensile-free state (εu), the residue strain after 
recovery (εp), and the maximum strain during the test (εm) were recorded as 94.3%, 1.9%, 
and 100%, respectively. Rr and Rf in the first cycle could be thus calculated as 98% and 
94% in the first cycle, respectively, based on two equations: 
( ) ( )[ ] %1001 ×−= mpmrR εεε  and ( ) ( ) %1001 ×= mufR εε . Most interestingly, SMP 
containing hyperbranched PCL has an extraordinary high Rf in the first cycle compared 
with the one using linear PCL.118 This may be due to the hyperbrached structure that 
helps to pin the chain against slippery. With the increased number of test cycles, Rr 
increased slightly and reached 99% in the third cycle (Table 5.2), while Rf was almost the 
same for all three cycles. The excellent Rr and Rf value make PCTBV-25 as a very 
attractive SMP for the fabrication of self-expandable stent, since high Rf is important for 





Table 5.2 Shape-Memory Proper ties of PCTBVs and PCDBVs Determined by 
Cyclic Thermomechanical Tensile Test. 
 




N(1)c N(2)c N(3)c N(1)c N(2)c N(3)c 
PCTBV-25 93 93 94 98 99 99 
PCTBV-30 94 95 95 98 99 99 
PCDBV-25 86 87 87 95 97 99 
PCDBV-30 87 88 89 95 97 99 
aRf for the fixity rate. b Rr for the recovery rate. Rf and Rr are determined by cyclic 
thermomethanical tensile test by heating up 65 oC, cooling to -15 oC and heating again to 
40 oC. 
 
5.3.4 Cytotoxicity test of PCTBVs. 
In the view of biomedical application, the cytotoxicity experiment was designed 
to simulate the clinic condition, determine the toxicological hazard of SMPs films (0.06-
0.08 mm in thickness), and evaluate the in vitro biocompatibility of the polymer. The 
sterilized films were soaked in complete culture medium over a period of 3 days at 37 oC. 
The extracts were used to incubate L929 cells, and the cytotoxicity was evaluated based 
on the ISO 10993 protocol by using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay. As shown in 
Figure 5.6, over 80% cell viability was observed for all cases, indicating no significant 
cytotoxicity to L929 cell. Therefore, the materials can be regarded as safe biomaterials 
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Figure 5.6 Viability of L929 cells after 3 days incubation in different concentrations of 
aqueous extracts of PCLBV and PCDBV films. 
 
In addition, the images (Figure 5.7) of L929 cells, after washed by medium to 
remove dead cells, demonstrated that the film surface of SMPs supported baseline L929 
cell attachment. Compared with the control, the cells on the film had extensive spreading. 
This indicates that cells are able to attach and grow on the material, and further confirms 
the in vitro biocompatibility of PCTBVs. 
 





5.3.5 Evaluation of PCTBV-25 as self-expandable stent. 
Finally, the application of the biodegradable SMP as self-expandable stent was 
examined. The self-expandability of stent is extremely important in the stent deployment 
because self-expandability counteracts the recoil of polymeric stents and allows for better 
anchoring. Ideally, the stent should completely expand to the pre-set diameter within a 
minute or less.255  Since PCTBVs are thermally-induced SMPs, it is important and 
necessary to process the stent from PCTBVs by heat treatment. The process of examining 
SMP as self-expandable stent was the followings (Figure 5.8): i) the film of PCTBV-25 
(0.21 mm in thickness) was first mechanically made on a metallic cylindrical rod with a 
diameter of 3 mm (outer diameter of 3.43 mm), heated to 55 oC for 15 min, cooled down 
to -20 oC for 15 min, and placed at room temperature for 30 min after removing 
mechanical force (outer diameter of 3.45 mm); ii) the film was mechanically deformed 
and fixed on a metallic cylindrical rod with a diameter of 1 mm (outer diameter of 1.42 
mm) by the same procedure described above to give the stent with outer diameter of 1.43 
mm; iii) the stent was put in water bath at 37 oC and the changes in the outer diameter of 
the stent were recorded by a highly accurate CCD micrometer. Remarkably, the outer 
diameter of this stent kept nearly unchanged and no recoil or premature expansion was 
observed after removing the mechanical force in step i) and ii). These results suggested 
good shape fixity at room temperature for the SMP. After putting into PBS solution at 37 
oC, the stent changed the outer diameter from 1.43 mm to 3.35 mm, which is nearly the 
full expansion (above 97% recovery), within only 30 s. A. These results suggest that the 






Figure 5.8 Photographs exhibiting the self-expansion of the stent made from PCTBV-25 
with original outer diameter of 3.45 mm. (1) The stent was mechanically deformed, fixed 
on a metallic rod with diameter of 1 mm to give outer diameter of 1.43 mm, and removed 
the mechanical force; (2)-(4) the stent was put in water bath at 37 oC after 3s, 10s and 
20s, respectively; (5) the stent was taken out from water bath after 25s, with diameter of 
3.35 mm. 
 
For comparison, linear SMPs (PCDBVs) from PCL-diol and PHBV-diol were 
also synthesized by the same two-step procedure. Their thermal, mechanical, and shape-
memory properties were determined. They showed Tm of 40 oC and 132-142 oC (Figure 
5.9), εb of 550-660%, бm of around 11 MPa, E of 42-60 MPa, Rr of 95%, and Rf of 86% 
(Table 5.2). Regarding to the shape-memory properties, PCTBVs are much better than 
PCDBVs. The material film of PCDBV-25 was then made into helical stents by the same 
procedure as for PCTBV-25. After removing the mechanical force, the diameter of this 
stent increased from 3.48 to 3.62 mm in step i) and from 1.47 to 1.59 mm in step ii). 
These data indicate the happening of premature expansion. This stent showed also self-
expandability at 37 oC, but with 92% recovery in 45 s. Thus, PCTBV-25 is much better 
than PCDBV-25 as self-expandable stent, with better fixation, better recovery, and faster 




than the linearly linked normal PCL for the preparation of biodegradable SMP for various 
biomedical applications. 













Figure 5.9 DSC curve for PCDBVs. 
 
5.4 Conclusion 
We developed the first SMP useful as biodegradable stent with fast 
selfexpandability. Novel block co-polymers PCTBVs containing dendrimer-like star PCL 
as switching segment and microbial polyester PHBV as crystallizable hard segment were 
designed and synthesized in excellent yield. PCTBVs showed desired thermal properties 
with a Tm of 40 oC from the switching segment suitable for thermal switching at body 
temperature and a Tm of 142 oC from the hard segment suitable for the stabilization of 
permanent shape in fabrication. PCTBVs demonstrated the ductile nature of the materials, 
and their mechanical properties were adjustable by changing the block ratio. PCTBV 
containing 25wt% PHBV (PCTBV-25) showed excellent shape-memory property at 40 




segment is much better than linear PCL-based one, giving rise to a high value of Rf. The 
novel microbial polyester PHBV hard segment contributed significantly to the excellent 
Rr. Both segments were developed for the first time and could be generally useful for the 
preparation of biodegradable SMPs. PCTBV-25 is a safe and biocompatible material 
according to cytotoxicity tests. The stent made from PCTBV-25 film showed nearly 
complete self-expansion at 37 oC in water bath within only 30 s, which is much better 
than the best known biodegradable stents. Therefore, the novel biodegradable block co-
polymer PCTBV-25 was successfully developed as an excellent SMP with thermal 
switching at body temperature and a biomaterial potentially useful as fast self-expandable 




CHAPTER 6 EVALUATION OF BIODEGREDADABLE 
SHAPE-MEMORY POLYMERS AS FULL POLYMERIC 
AND SELF-EXPANDABLE DRUG-ELUTING STENT 
 
6.1 Introduction 
Over the past years, the treatment of coronary artery disease has made significant 
progress with the development of percutaneous transluminal coronary angioplasty 
(PTCA).217 Nevertheless, PTCA also causes restenosis of treated arteries resulting in 
abrupt or chronic closure. 33, 218, 219 To overcome this side effect, bare-metal stent (BMS) 
was developed and proved for the treatment of threatened vessel closure after failure with 
PTCA.34-36, 220, 221 However, BMS may cause neointimal hyperplasia leading to in-stent 
restenosis.34-36 To overcome this side effect, drug-eluting stent (DES) was developed, 
which was made from BMS by coating with nonresorbable polymer for drug loading.41 
DES could inhibit vascular smooth cell migration and proliferation with the locally 
released drug.222-227 In spite of the effectiveness of DES in reducing restenosis, it 
simultaneously caused the inflammatory reaction and inhibited the healing of vessel wall, 
thus leading to the thrombogenesis.228-230 Subsequent researches indicated that the 
existence of non-degradable polymer coating may continue to incite a local inflammatory 
reaction and caused thrombogenesis.226, 231 This may be lowered to some extent with 
biodegradable polymeric stents that could be degraded to non-toxic products after 
completion of their functions.  
The first biodegradable and fully polymeric stent was developed from PLLA by 




the remove of balloon may lead to vessel injury.39 To avoid, the real self-expansion stents 
were developed by the incorporation of elastic memory in the polymer, with the fastest 
self-expansion time at 2.5 min.39 As an important parameter, the self expansion time is 
suggested to be ideally less than a minute to avoid the migration after deployment.40 So 
far, there is no success on fully polymeric and biodegradable drug-eluting stent with 
rapid self-expandability. In the only known example, biodegradable chitosan stent was 
used as drug-eluting stent with more than 2 min for self-expansion and extremely fast 
drug release (over 50%) in the first 2 days properly due to its relatively high 
hydrophilicity.42 To speed up the self-expansion time and achieve slow but controlled 
drug release, hydrophobic SMP might be the better suitable material for biodegradable 
drug-eluting stent. 
SMPs have the capability to remember their original shapes when exposed to 
external stimulus, e.g. heat. Thermally-induced SMPs often have two-phase 
heterogeneous structure consistsing of at least two segments, switching and hard 
segments. The switching segment is a reversible phase that determines Ts either by the 
glass transition (Tg) or the melting transition (Tm). The glass transition possesses a board 
transition zone which may retard the shape recovery. Thus, the Tm-dependent SMP is 
more preferred due to the fast and sharp shape recovery. For this reason, the most 
promising switching segment for biodegradable SMPs is Tm-dependent poly(ε-
caprolactone) (PCL). We previously developed three-arm PCL and hyperbranched PCL 
as switching segment with Ts around body temperature for PCL-PU and PCL-PHBV 
SMPs. The latter was used as fast self-expandable stent with full expansion within 25 s. 
Therefore, the hyperbranched PCL should be the suitable switching segment for SMPs as 




relatively slower degradation and active for over a year, thus being suitable for drug-
eluting purposes.46, 47 On the other hand, the hard segmen is a rigid fixed phase that is 
responsible to memorize the original shape through forming physical netpoints or 
chemical cross-links. Physically cross-linked segmented polyurethanes as SMPs are 
particularly attractive due to good shape-memory properties from the phase separation 
between two incompatible segments which brings about the properties related to blood 
compatibility. 
Considering the application as drug-eluting stent, we are would like to evaluate 
new hard segment, poly(2-Oxepane-1,5-dione) (POPD) in stand of PHBV. POPD had 
been demonstrated as elastomeric biodegradable scaffold.269 Thus usage of elastomeric 
biodegradable scaffold could avoid the heterogeneous degradation, nonlinear loss of 
strength and mechanical failure with time. On the other hand, POPD has more ketone in 
the system which increased negative charge of the material surface, thus leading to good 
compliance with blood. Additionally, the use of POPD could introduce additional 
hydrogen bonds that could not only enhance the mechanical property but also increase 
the driving force for phase separation for leading to better shape-memory property. Last 
but not least, this hydropobic SMP extremely fits to deliver of lipophilic characteristic of 
paclitaxel. 
 In this paper, we report the synthesis and characterization of a series of new SMPs 
containing POPD as hard segment and hyperbranched PCL as switching segment. PCL-
triol was reacted with 4,4'-methylenediphenyl diisocyanate (MDI) to form hyperbranched 
PCL prepolymer which was then connected with POPD and MDI to give poly(ester–
urethanes). In the end, the first example of using SMP as fast self-expandable and 




6.2 Materials and methods  
6.2.1 Synthesis of 2-Oxepane-1,5-dione (OPD) 
2-oxepane-1,5-dione (OPD) was synthesized by the Baeyer-Villiger oxidation of 
1,4-cyclohexanedione as reported.32 1,4-cyclohexanedione (10g 8.9 mmol) and 3-
Chloroperbenzoic acid (m-CPBA) (19.40 g 11.25 mmol) in dichloromethane were 
refluxed at 40 oC  for 4 h. After the reaction, the solvent was evaporated under reduced 
vacuum and the residue was washed by cold diethyl ether for 4 times. The raw product of 
2-Oxepane-1,5-dione was dried by anhydrous Na2SO4 followed by dissolving in dry 
toluene and cooling down to 4 oC overnight under argon. 6.2 g 2-Oxepane-1,5-dione 
crystal with 56% yield was obtained after collected from toluene and vacuum dried.  
 
6.2.2 Synthesis of poly(2-Oxepane-1,5-dione)-diol (POPD) 
Dried OPD (10g, 7.8mmol) was dissolved in dry toluene (40 mL) followed by 
adding ethylene glycol (8.06mg, 0.13mmol) and Sn(Oct)2 (6.5mg 0.016mmol) in the 
reaction mixture.270-272 The reaction was stirred under argon for 14 h at 90 oC. Light 
yellow solid was precipitated and recovered by filtration. The crude product was washed 
by dicholormethane and methanol before being dried in vacuum oven. POPD (6.95g, 
69% yield) was characterized by 1H MNR, GPC and DSC showing a Mn of 1920 g/mol 
(NMR) and a Tm of 137 oC (DSC). 
 
6.2.3 Synthesis of poly(ester -urethane)s (PCTOPD)s containing 




A mixture of PCL-triol (4.00 g) and MDI (0.59 g) in dry DMF (20mL) was stirred 
at 75 oC for 8 h under argon. A solution of POPD-diol (1.7 g) in dry DMF  (10 mL) were 
added, followed by stirring at 90 oC for 44 h. Afterwards, the reaction mixture was 
poured into methanol (90 mL), and the mixtures were stirred for 1 h at room temperature. 
The product was then precipitated, collected by filtration, washed three times with 
chloroform/dioxane/methanol, and dried under vacuum for 24 h to give 5.95 g PCTOPD 
with 94.7% yield. The polymer showed a Mn of 57300 g/mol analyzed by GPC with 
DMF as solvent and polystyrene as standards, and Tm of 40 oC and 122 oC for switching 




6.3. Result and Discussion 
6.3.1 Synthesis of  poly(2-Oxepane-1,5-dione)-diol (POPD) 
 
 






2-Oxepane-1,5-dione (OPD) was synthesized according to the reported method. 
The raw product was recrystallized from dry toluene at 4 oC. The crystal was collected by 
filtration and dried under reduced vacuum overnight, giving 6.2 g OPD with 56% and 










Figure 6.1 1H NMR spectrum of 2-oxepane-1,5-dione CDCl3. 
 
Poly(2-Oxepane-1,5-dione)-diol (POPD-diol) was prepared by the ring-opening 
polymerization of OPD with ethylene glycol as initiator and stannous octoate as catalyst, 
shown in Scheme 6.1. Different reaction conditions including the ratios of OPD with 
ethylene glycol (EG), OPD with catalyst (Cat), and reaction time were investigated. After 
the reaction, POPD-diol was precipitated, collected by filtration, washed with chloroform 
and methanol, and dried in vacuum oven. The reaction conditions and results were 




diol, which was changed from 1870 to 2330 g/mol with increasing the ratio of OPD/EG 
to 60:1. With the increase of Mn from 1870 to 2330 g/mol, Tm of POPD also increased 
from 117 to 137 oC. The reaction time between 14h and 30h as well as the decrease in 
catalyst concentration for 500:1 to 1000:1 had no significant influence on Mn of POPD-
diols. 























1 60:1 500:1 4:1 14 90 69 137 2330 1920 
2 30:1 500:1 4:1 14 90 74 117 1870 / 
3 60:1 500:1 4:1 30 90 71 135 2410 / 
4 60:1 1000:1 4:1 14 90 62 129 2050 / 
a EG for ethylene glycol. b Cat for stannous octoate. c Sol for solvent, toluene. d Mn was 
determined by GPC with polystyrene as standards in DMF. e Mn was calculated by NMR 
in d6-DMSO at 60 oC. 
 
 The chemical structure of POPD-diol was determined by NMR analyses in 
DMSO-d6 at 333 K. 1H and 13C NMR spectra of POPD-diol with Tm of 137 oC and Mn of 
2330 g/mol (GPC) were shown in Figure 6.2 and 6.3, respectively. In the 1H NMR 
spectrum, the disappearance of signal of ethylene glycol at 3.5 ppm indicated the 
occurrence of the reaction. In addition, signal (2.68-2.73 ppm) of CH2-OCO shifted to 
2.43-2.48 ppm and the signal (2.8-2.9 ppm) of CH2-CO split into two peaks confirmed 
the reaction between OPD and ethylene glycol. The signal of H-(6) corresponding to 
CH2-OH end group was absorbed at 3.65-3.67 ppm. All signals could be assigned to the 
corresponding proton of the proposed structure of POPD-diol (Figure 6.2). Therefore, the 




(7) and H-(7’) and Mn of POPD-diol was accordingly deduced as 1920 g/mol, which was 




Figure 6.2 1H NMR spectrum of poly(2-oxepane-1,5-dione)-diol in d6-DMSO at 333 K. 
 
The chemical structure of POPD-diols was further confirmed by 13C NMR 
analysis (Figure 6.3). All signals could be assigned to the carbons of PCL-triols. The 
signal intensity for the repeating unit [C-(a-f)] was much higher than that for the terminal 
carbons [C-(a’-f’)]. The end group CH2-OH C-(f’) of was clearly observed at 56.2 ppm. 
C-(x) from ethylene glycol appeared at 61.7 ppm. The signals of -COO-group [C-(a)] and 







Figure 6.3  13C NMR spectrum of poly(2-oxepane-1,5-dione)-diol in d6-DMSO. 
 
 
6.3.2 Synthesis of poly(ester -urethane)s (PCTOPD) containing 
hyperbranched three-arm PCL block and POPD block 
New SMPs was prepared by two-step reaction, shown in scheme 6.1. The reaction 
conditions and results were listed in Table 6.2.  
Initially, hyperbranched PCL as switching segment was synthesized by the 
reaction of PCL-triol (Tm=47 oC, Mn=4200 g/mol) with methylene diphenyl diisocyanate 
(MDI) in DMF at 75 oC for 8 h. To confirm the structure, a sample (PCLols) was taken 
from the reaction mixture for 1H NMR analysis. The rest was further reacted with POPD-
diol (Tm=137 oC, Mn=1920 g/mol) at 90 oC for 44 h. In the 1H NMR spectrum of PCLols 




indicated the happening of the polymerizations. According to the method developed 
previously, the ratio of H-(11)/H-(17) should be 11.7x2x3xy/(y+2), if we assume y PCL-
triol linked together. Thus, y was calculated as 7.3, suggesting that about 7 PCL-triols are 
on average linked together via MDI. This corresponds to a Mn of 30660 g/mol for 
PCLols, being very close to the Mn obtained from GPC. The hyperbranched PCL showed 
a Tm of 38.5 oC and a Xc of 30% in the DSC curve.  
Table 6.2. Molecular weight and thermal properties of PCTOPDs. 
 












DMFa THFb NMRc 
POPD-diol 0 45 - 137 - 2330  1920 
PCLTd 100 63 47 - 67  4000 4100 
PCLols 91 - 38.5 - 30 29400  30600 
PCTOPD-15e 71 89.8 40 122 31 40120   
PCTOPD-20 66 94.1 39.3 120 30 49800   
PCTOPD-27 65 94.7 40 121 36 57300   
PCTOPD-35 64 96.3 40 129 29 71400   
a Mn was determined by GPC with polystyrene as standards in DMF. b Mn was determined 
by GPC with polystyrene as standards in THF. c Mn was calculated by NMR in d6-DMSO 
at 60 oC. d PCLT for PCL-triol. e PCTOPD-15 for PCTOPD containing 15 wt% POPD. 
          
A series of poly(ester-urethanes) (PCTOPDs) containing 15-37 wt% of POPD 
were prepared with overall yield of of 89.8-96.3% and shown Tm of 39-40 oC and Xc of 
29-35%. The molecular weight and thermal properties were measured by GPC and DSC, 
and the results were given in Table 6.2. All PCTOPDs showed the similar Tm of 40 oC for 
switching segment and Tm of over 120 oC for hard segment. Therefore, POPDs Tm of 







Figure 6.4  1H NMR spectrum of PCLols in d6-DMSO at 333 K. 
 
6.3.3 Mechanical proper ties of PCTOPDs 
Mechanical testing for PCTOPDs was performed on “dog-bone” tensile bars 
originating from solvent-cast films (0.2-0.3 mm in thickness) on Microforce Tester 
Instron 5569 with a deformation rate of 5 mm/min at room temperature. Young’s 
modules (E), elongation at break (εb) and maximum tensile strength (σm) were obtained 




strain plot for PCTOPD-27 pulled to ultimate failure. This materials displayed εb of 
990%, σm of 20 MPa, and E of 91 MPa. Compared with PCTBV-25 in previous chapter, 
PCTOPD-27 exhibited a linear response at low strain followed by strain-hardening before 
breaking. It also revealed a 1.8 -fold increase in σm, 2-fold increase in E and 1.6 -fold 
increase in εb compared with PCTBV-25. This significant change in mechanical property 
is attributed to the enhanced inherent interaction, which stemmed for the introduction of 
additional hydrogen bond with the increase in ketone group in the hard segment. With the 
increase in POPD weight content from 15% to 27%, E and σm were increased from 70 to 
91 MPa and 12 to 20 MPa, respectively.  























PCTOPD-15 60 1060 12 88 92 90 94 95 97 
PCTOPD-20 70 908 17 90 94 94 96 95 99 
PCTOPD-27 91 990 20 95 97 97 98 97 99 
PCTOPD-35 128 244 12 93 98 94 98 96 99 
a E for Young’s modulus. b εb for for the elongation at breakage. cσm for maximum tensile 
strength. εb, σm and E are determined by tensile test with a deformation rate of 5 mm/min 
at 25 oC. d Rf(N=1,2,3) for Rf obtained in the Nth cycle of thermomechanical tensile tests. 



















Strain (%)  
Figure 6.5 The strain-stress curve for PCTOPD from tensile test 
 
 
6.3.4 Shape-memory proper ties of PCTOPDs. 
The performance of SMPs is evaluated by two important parameters, shape-
recovery rate (Rr) and shape-fixity rate (Rf). To quantify Rf and Rr, cyclic 
thermomechanical tensile test was conducted (Table 6.3). The original shape of PCTOPD 
films was first elongated to 150% at 65 oC, the temporary shape was fixed under stress 
control mode by cooling to -15 oC, and the recovery at 40 oC in air was determined under 
stress-free mode. Due to the low elongation at breakage of PCTOPD-35, it was elongated 
to 70% for the quantification of shape-memory effect. Three cycles were carried out 
using the same method. After the test, the stain-stress curve was recorded and the 
representative profile of PCTOPD-27 was shown in Figure 6.6. From the curve, the strain 
in the tensile-free state (εu), the residue strain after recovery (εp), and the maximum strain 
during the test (εm) were recorded as 142.7%, 4.4%, and 150%, respectively. The Rf and 
Rr could be calculated as 95% and 97%, respectively. Theoretically, the shape-memory 




at higher deformation strain. However, PCTOPD-27 still exhibited high Rf and Rr even at 
higher deformation of 150%. Rf was slightly higher than PCTBV-25 in previous chapter, 
probably due to the improved phase separation by the introduction of additional hydrogen 
bond. Almost complete recovery was observed after the third cycle test. The excellent Rr 
and Rf value make PCTOPD as a very attractive SMP for the fabrication of self-
expandable stent, since high Rf is important for avoiding premature expansion and recoil, 
while high Rr is essential for complete self expansion.  


















Figure 6.6 Strain-stress curve of PCTOPD-27 from cyclic thermomechanical tensile tests 
with εm of 150%. The film was elongated to εm of 150% at 65 oC, cooled down to -15 oC, 
kept at -15 oC and unloaded, and then heated to 40 oC. 
 
6.3.5 Cytotoxicity and biocompatibility of PCTOPDs 
The in vitro biocompatibility was evaluated by the cytotoxicity experiment, which 
was designed to simulate the clinic condition. The PCTOPDs films were applied to 
determine the toxicological hazard. The method is similar to PCTBV materials in 




over a period of 3 days at 37 oC. The extracts were used to incubate L929 cells, and the 
cytotoxicity was evaluated based on the ISO 10993 protocol by using the 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
(MTS) assay. The results were shown in Figure 6.7. Over 80% cell viability was 
observed for all cases, indicating no significant cytotoxicity of the extract of PCTOPDs 
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Figure 6.7 Viability of L929 cells after 3 days incubation in different concentrations of 
aqueous extracts of PCTOPD films. 
 
6.3.6 Evaluation of PCTOPD-27 as self-expandable stent. 
Finally, the application of the biodegradable PCTOPDs as self-expandable stent 
was examined. As an example, the PCTOPD-27 film (0.13 mm in thickness) was wound 
and fixed on a metallic cylindrical rod with a diameter of 3 mm (outer diameter of 3.26 




at room temperature for 30 min, and a stent with outer diameter of 3.28 mm was obtained 
after removing mechanical force. The film was then mechanically deformed and fixed on 
a metallic cylindrical rod with a diameter of 1 mm (outer diameter of 1.26 mm) by the 
same procedure described above to give the stent with outer diameter of 1.27 mm. 
Finally, the stent was put in PBS buffer at 37 oC and shape change occurred. As shown in 
Figure 6.8, the stent was able to be self expanded in PBS buffer at 37 oC and it stopped 
expansion after 45 s.  
 
Figure 6.8 Photographs for the self-expansion of stent from PCTOPD-27 in PBS buffer at 
37 oC. 
 
To further quantify the self-expandability of PCTOPD stent, the change of outer 
diameter was monitored by a highly accurate CCD micrometer and the result was 
displayed in Figure 6.9. With monitoring the change in outer diameter, it revealed that the 
outer diameter of this stent kept nearly unchanged after removing the force, which helps 
to better in vivo anchoring. The stent from PCTOPD-27 reached a full expansion within 




important in the stent deployment because fast self-expansion can avoid the migration 
after deployment. Therefore, the results suggest that the novel biodegradable SMP is a 
potentially useful material as fast self-expandable stent. 
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Figure 6.9 The influence of PCL weight content on the self-expandability of PCTOPD 
stent in PBS buffer at 37 oC. 
 
6.3.7 In vitro drug release of PCTOPD stents. 
Finally, PCTOPD self-expandable stent was examined as drug-eluting stent. 
Paclitaxel (3.0% wt) was blended into PCTOPD films, which was made into paclitaxel-
eluting stent. It was then immersed into PBS buffer and placed in water-bath shake with 
120 pm at 37 oC. The released drug was extracted from PBS buffer by using 
dichloromethane and analyzed by HPLC with water/acetonitrile (1:1 v/v) as eluent. The 
results of PCTOPD-27 and PCTOPD-15 for in vitro drug release were shown in Figure 
6.10. The stent displayed a nearly linear sustained release profile in the first 10 days. 




respectively. Compared with sirolimus-eluting stents (Figure 6.10),44 paclitaxel-eluting 
stent from PCTOPD exhibited a slower drug release. More importantly, no apparent burst 
release was observed even at the beginning of drug release. The relatively slow drug 
release was possibly attributed to more hydrophobic nature of PCTOPD SMP, thus 
retarding the releasing of paclitaxel. This property was also clearly reflected in the 
different release speed of PCTOPD-15 and PCTOPD-27: PCTOPD-15 with more PCL 
weight content showed a relatively slower release profile than that of PCTOPD-27. This 












Figure 6.10 The drug release profiles of paclitexal from PCTOPD stents. The 
biodegradable and self-expandable chitosan material was used to make sirolimus-eluting 
stent with 2.5 wt% of sirolimus. 
 
6.3.8 Collapsed pressure of PCTOPD-27 stents. 
  Since there was no condition to mimick the physiological flow rate within the 
human artery, the collapsed pressure of stent from PCTOPD-27 was evaluated by the 




taken out and immediately performed by compression test, shown in Figure 6.11. It could 
be seen that the collapsed pressure of the test stent was 1.7 bar, which was totally higher 
than the physiological pressure of 1 bar in human body.  
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Figure 6.11 Compression curve for stent from PCTOPD-27 with the thickness of 0.22 
mm and out diameter of 3.45 mm. 
 
 Moreover, other researches revealed that the degradation rate of poly(CL-co-
OPD). It was reported that poly(CL-co-OPD)  with 30% mol OPD showed a degradation 
rate of approximately 15% in 20 weeks.259 PCTOPD-27 has the similar OPD 
concentration as the reported randaom copolymer. Based on this, we assumed that the 
stent from PCTOPD-27 has the same degradation rate as the reported one, suggesting that 
the stent should be able to maintain the strength for more than 6 months to reduce in-stent 
restenosis in human body. Therefore, the new developed stent could be a very promising 
drug-eluting stent in the treatment of coronary artery disease. In future, the degradation 




This thermoplastic elastomer material PCTOPD (15-27) will be extremely 
suitable for drug-eluting stent. Firstly, it has high collapsed pressure of 5.8 bar, which is 
more than enough to keep the vessel.  Secondly, its thermoplastic nature will bring about 
the property related to blood compability. Thirdly, its elastomeric nature will avoid the 
stent from the heterogeneous degradation and mechanical failure with time. Last but not 
least, the stent or paclitaxel-eluting stent from PCTOPD shows a fast self-expansion and 
sustained drug release at 37 oC. 
 
6.4 Conclusions  
Shape-memory block co-polymers PCTOPDs containing hyperbranched three-arm 
PCL as switching segment and POPD as crystallizable hard segment were designed and 
synthesized in excellent yield. PCTOPDs showed desired thermal properties with a Tm of 
39-40 oC from the switching segment suitable for thermal switching at body temperature 
and a Tm of 120-122 oC from the hard segment suitable for fixing the permanent shape. 
The PCTOPDs (15-27) was shown to be thermoplastic elastomer. The best result of σm of 
20 MPa, E of 91 MPa and εb of 990% was obtained from PCTOPD-27. The high stress 
makes this material suitable for the application as scaffold and its ductile nature leads to 
the easy fabrication of stent. Furthermore, the elastomeric nature could avoid the stent 
from the heterogeneous degradation and mechanical failure with time, while its 
thermoplastic nature could bring about the property related to blood compability. 
PCTOPDs(15-27) showed excellent shape-memory property with Rf of 95% and Rr of 
97% at a deformation rate of 150% as well as recovery time of 35s. A nearly complete 
recovery was observed after three cycles. The cytotoxicity test showed that PCTOPDs 




complete self-expansion at 37 oC in PBS buffer within 45 s. It displays collapsed pressure 
of 5.8 bar, which is much higher than the physiological pressure of 1 bar. The paclitaxel-
eluting stent from PCTOPD 15 and PCTOPD-27 showed a sustained drug release profile 
and could continuously release in 30 days. Since, poly(CL-co-OPD) with 30% mol OPD 
is known to has a slow degradation rate, thus being able to keep the strength and maintain 
the vessel for more than 6 months to reduce in-stent restenosis. In a word, the 
biodegradable and non-cytotoxic thermoplastic elastomer (PCTOPD) was demonstrated 
as an excellent SMP with thermal switching at body temperature, shown to be fast self-
expandable stents in 45 s, and examined as paclitaxel-eluting stent with sustained drug 




CHAPTER 7 CONCLUSION AND RECOMMENDATIONS 
 
7.1 Conclusion  
Shape-memory polymers (SMPs) are able to change shapes upon the application 
of external stimulus. Recently, the research on SMPs mainly focuses on the development 
of thermally-induced SMPs for biomedical application. Among these, physically-cross-
linked shape-memory segmented polyurethanes, that exhibit phase separation between 
the incompatible soft and hard segment and bring about the property related to blood 
compatibility, have received great attention as biomaterials for the application as 
implants for minimally invasive surgery. Poly(ε-caprolactone)-co-polyurethanes  are the 
most popular SMPs because the PCL-segment shows Tm-dependent shape-memory effect, 
featuring a sharp and fast recovery, and both PCL and PU are biodegradable, thus 
avoiding the second surgery to remove the implant. One of the prerequisites of SMPs for 
such application is the switching temperature (Ts) at body temperature. While the 
reported linear PCL segment is hardly to reach this target, three-arm PCL was 
successfully developed as the switching segment with Ts around body temperature in this 
PhD thesis. Three-arm PCL-triol was synthesized by lipase-catalyzed ROP of ε-
caprolactone (CL) with glycerol, with high yield, controlled molecular weight, defined 
structure, and desired property. The enzymatic method is much better than the metal-
catalyzed ROP regarding the purity and properties of the product.  Three-arm poly(ester-
urethanes) (tPCL-PU) containing three-arm PCL switching segment and PU hard 
segment was prepared by controlled reaction of three-arm PCL, MDI, and HD. The 




properties with Ts of 38 oC. Compared with linear PCL, three-arm PCL has a higher 
excluded volume which may improve crystallilinity and phase separation, thus leading to 
Ts at body temperature and a better shape recovery. This SMP produced stress in the 
range of 2 to 3 MPa, which resembled the mechanical stresses in soft tissue. Thus, we 
have achieved the successful designing and syntheses of the first three-arm PCL as 
switching segment and the first three-arm SMP, with good shape-memory properties at 
room tempaeraure and good mechanical properties for soft tissue engineering. 
To achieve good process stability, recovery stress, recovery time, and shape-fixity 
rate, new SMP containing both crystallinable switching and hard segment was designed 
and developed. Firstly, microbial polyester PHBV was developed as hard segment, due to 
its good biocompatibility, low degradation rate, and high Young’s modulus to adjust the 
stress. Secondly, three-arm PCL was further modified and developed to hyperbranched 
PCL as switching segment, which serves as additional netpoints to prevent the chain from 
slippery and hence improve shape fixity. The hyperbranched PCL segment is much better 
than linear PCL-based one, giving rise to a higher value of Rf. The novel microbial 
polyester PHBV hard segment contributed significantly to the excellent Rr. Both 
segments were developed for the first time and could be generally useful for the 
preparation of biodegradable SMPs. Block co-polymers PCTBVs containing 
hyperbranched three-arm PCL and microbial polyester PHBV were synthesized in 
excellent yield. PCTBVs showed desired thermal properties with a Tm of 39-40 oC from 
the switching segment suitable for thermal switching at body temperature and a Tm of 142 
oC from the hard segment suitable for the stabilization of permanent shape in fabrication 
as well as potential thermal sterilization procedure. PCTBVs demonstrated the ductile 




block ratio. PCTBV containing 25wt% PHBV (PCTBV-25) showed excellent shape-
memory property at 40 oC with Rf of 94%, Rr of 98%, and shape recovery within 25s. 
A biodegradable SMP was examined as fast self-expandable stent. The stent made 
from PCTBV-25 film showed nearly complete self-expansion at 37 oC within only 25 s, 
which is much better than the best known biodegradable stents. PCTBV-25 is also a safe 
material with good biocompatibility according to cytotoxicity tests and cell growth 
experiments. Therefore, the biodegradable and non-cytotoxic block co-polymer PCTBV-
25 with excellent sharp-memory properties and thermal switching at body temperature is 
a potentially useful biomaterial as fast self-expandable stent or stent cover. 
New SMPs were designed and developed for self-expandable drug-eluting stent. 
While the hyperbranched PCL switching segment was used as the switching segment, 
new hard segment was further developed. To enhance the interaction with drug and 
further modify the mechanical and shape-memory properties, poly(OPD) was evaluated 
as the hard segment. Poly(OPD) with Mn of 1920 g/mol and Tm of 137 oC was prepared 
by stannous octoate-catalyzed ring-opening polymerization ROP of OPD with ethylene 
glycol as initiator. The new SMP PCTOPDs containing hyperbranched PCL and POPD 
was prepared by linked with MDI. This material showed a switching temperature at 40 oC 
with good mechanical property (εb of over 980%, σm of 14-20 MPa and E of 70-91 MPa) 
and excellent shape-memory property (Rf of over 95% amd Rr of over 97% at a 
deformation of 150%). Due to the introduction of additional ketone groups and the 
formation of more hydrogen bonds, a 1.8-fold increase in maximum stress, 2-fold 
increase in Young’s modulus and 1.6-fold increase in elongation at breakage were 
observed when compared PCTOPD-27 with PCTBV-25.  PCTOPD was also established 




thermoplastic nature could bring about the property related to blood compatibility and its 
elastomeric nature could avoid the stent from the heterogeneous degradation and 
mechanical failure with time. In addition, the increased hydrogen bonds also increased 
the phase separation, thus resulting in better shape-memory property even at a 
deformation of 150%. PCTOPD was demonstrated as a non-cytotoxic material. The stent 
from PCTOPD also showed a full and fast expansion at 37 oC within 45 s in PBS buffer. 
Paclitaxel (3.0 wt%) was then loaded on the stent  which showed a nearly linear sustained 
drug release in the first 10 days of 33-42%, reaching 55-67% after 30 days. In addition, 
the stent also had a collapsed pressure of 1.7 bar, higher than the physiological pressure 
of 1 bar. Hence, this stent was able to keep the vessel wall from restenosis. The first 
application of SMP as fast self-expandable drug-eluting stent for the potential treatment 
of coronary artery was successfully demonstrated. 
 
7.2 Future Work 
The future work would focus on improve shape-memory properties, detect the 
degradation rate, examine the blood compatibility and develop new application of SMPs.  
In this Ph. D work, we developed three-arm PCL and hyperbranched PCL as 
switching segment for the preparation of thermoplastic Tm-dependent shaoe-memory 
polymer (SMPs). It is found that the crystallinity of the switching segment plays an 
important role in the performance of shape-memory properties. For example, low 
crystallinity of the switching segment (PCL) resulted in the low shape-fixity rate (Rf) of 
SMPs. Thus, it is necessary to futher study the crystallinity of switching segment by 
XRD, which would give us more information than DSC. Meanwhile, to further modify 




isothermal crystallization of SMP. From this study, we can thoroughly study whether the 
crystallization behavior of PCL is suppressed or promoted by the hard segment (PHBV or 
POPD).  This would help us to design the material and set up the proper programming 
method to analyze the shape-memory property.  
For biodegradable polymers used as implants, the degradation kinetics is the key 
parameter that influences the performance of implants because a nonlinear mass loss of 
implants could lead to a sudden release of potentially acidic degradation products that 
may caus a strong inflammatory reponse. More importantly, the matrials must maintain 
their biostability and biofunctionality during degradation to avoid graft failure. In terms 
of using as stents, they are required to maintain the scaffolding strength for at leat 6 
month in order to prevent the restenosis of blood artery and recoil of stents.37 Thus, the 
degradation kinetics of materials and the influence on the mechanical property of stents 
are adviced to carry on for PCTBV and PCTOPD stents, which could be the guidance for 
us to further modify SMP architecture.  
Nowdays, the most significant impediment in the clinic application of blood-
contacting medical device is the biomaterial-induced blood coagulation, which is caused 
by the blood interaction with foreign materials.273 Among all the interactions, the 
formation of thrombus, irritated by intimal hyperplasia is the most important reason for 
the failure of small-diameter vascular stents.274, 275  Thrombosis is mainly due to 
dysfunctional endothelization, related to platelet adhesion and aggregation on stent 
surface.276-278 Thus, it is very important to conduct in vitro platelet adhesion study for the 
PCTBV and PCTOPD stents. If the result is far from statisfactory, further study and 
surface modification of the developed stent should be applied. For example, the 




adhesion and aggregation is reported to be significantly related to hydrophobic or 
hydrophilic nature. The reason is that the adsorption of blood proteins is a selective 
process: serum albumin is selectively adsored onto hydrophilic segment, while globulin 
and fibrinogen tend to adsorb onto hydrophobic segment.279 The organized structure of 
adsorbed blood protein may prevent platelet activation. Therefore, an optimaizaion of the 
hydrophobic-hydrophilic ratio as surface modification should be conducted to improve 
blood compatibility. Considering the more hydrophobic nature of our developed 
materials, surface modification such as coating with collegan or incorporation of PEG to 
improve the hydrophilicity of the material can be considered as one of the solutions. 
Furthermore, the surface charge of the material surface has some effect on blood 
compatibility. It is reported thet a synergistic effect of both charges on protein adsorption 
created a favorable surface to promote blood compatibility. Hence, chemical surface 
modification of materials into zwitterionomer-type polyurethane may be the other option 
for suppressing platelet adhesion and aggregation. 280 Finally, the size and organization of 
hard and switching domain after phase separation also have an influence on platelet 
adhesion and aggregation. The nano-sized domain is reported to improve blood 
compatibility.281 Thus, nano-engineering could also be considered. To achieve the 
success in stents application, an effective way is to develop antithrombogenic materials to 
suppress platelet adhesion and aggregation or improve endothelial cell spreading and 
proliferation. Thus, other methods such as grafting of gelatin to improve endothelial cell 
proliferation, attachment of endothelial cell and nclusion of anti-platelet agents etc can 
also be the reference.  
Subsequently, in vivo study of stents is recommended. For example, to study the 




proliferation of smooth muscle cells in cell-cycle stages could be investigated. In vivo 
stent efficacy could also be evaluated to demonstrate the developed palitaxel stent in 
preventing in-stent restenosis and neointimal formation, which is the key requirement of 
the developed stent further applied in clinic trial on human body and commercialized.  
The application of thermally-induced SMPs could be further explored. One very 
promising application of deployable structures is the deployable thin film applied in 
aircraft and spacecraft application. To save storage space, the deployable thin film should 
be able to be folded and expanded to their full size after shape-recovery. The key issue is 
to develop SMP with steady and well-controlled recovery because a suddenly and 
uncontrolled recovery may vibrate the satellite in space. Thus, the designing of suitable 
SMPs is the prerequisites for this application.  
In addition, SMPs with new trigger mechanisms, such as magnetics and light etc, 
could also be developed for other applications. Moreover, SMPs capable of memorizing 
two or more temporary shapes are also very interesting and potentially able to offer more 
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